name,SMILES,target,species,type,value
Varenicline,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21,Acetylcholine receptor protein alpha/beta/delta/gamma chain,Torpedo californica,Ki, 3540
Varenicline,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21,Neuronal acetylcholine receptor protein alpha-4/beta-4 subunit,Rattus norvegicus (Rat),Ki, 28
Varenicline,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21,nAChR alpha4 beta2 subtype,Rattus norvegicus (Rat),Ki, 0.12
Varenicline,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Homo sapiens (Human),Ki, 0.12
Varenicline,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21,Neuronal acetylcholine receptor protein alpha-3/beta-4 subunit,Rattus norvegicus (Rat),Ki, 460
Varenicline,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21,Neuronal acetylcholine receptor protein alpha-3/beta-4 subunit,Rattus norvegicus (Rat),Ki, 390
Varenicline,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21,Neuronal acetylcholine receptor protein alpha-3/beta-2 subunit,Rattus norvegicus (Rat),Ki, 2.5
Varenicline,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21,Neuronal acetylcholine receptor,Rattus norvegicus (Rat),Ki, 0.12
Varenicline,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21,Neuronal acetylcholine receptor protein alpha-2/beta-4 subunit,Rattus norvegicus (Rat),Ki, 94
Varenicline,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21,Neuronal acetylcholine receptor,Rattus norvegicus (Rat),Ki, 32.5
Varenicline,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21,Neuronal acetylcholine receptor protein alpha-2/beta-2 subunit,Rattus norvegicus (Rat),Ki, 0.48
Varenicline,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21,Neuronal acetylcholine receptor protein alpha-7 subunit,Homo sapiens (human),Ki, 125
Varenicline,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Homo sapiens (Human),Ki, 0.11
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 25107
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 153
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 18458
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 302
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 22500
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 191
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Voltage-gated potassium channel,Homo sapiens (human),IC50, 3981071.71
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 19944
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 1183
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 211
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 3370
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 561
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 10700
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 25
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 130
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 2031
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,perilipin-1,Homo sapiens,IC50, 15707
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 4517
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 177
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine transporter,BOVINE,Ki, 197
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine Monoamine transporters,Rattus norvegicus,Ki, 2000
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 480
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 23547
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,OPIATE Sigma,RAT,Ki,>10000
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 257
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 139
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 5801
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 327
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 1020
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 10400
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Hepatocyte nuclear factor 4-alpha,Homo sapiens,IC50,>39849
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine transporter,RAT,Ki, 119
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 25733
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 1377
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 10000
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 1
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 196
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 130
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 257
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 220
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 139
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 195
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 32
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 371
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 8
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Serotonin 3a (5-HT3a)/3b (5-HT3b) receptor,Homo sapiens (Human),Kd, 20
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 26808
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,perilipin-5,Homo sapiens,IC50, 9390
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 211
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 668
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 15756
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 96
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 668
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 380
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki,>10000
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 127
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 20
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 78200
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 368
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki,>10000
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Voltage-gated potassium channel,Homo sapiens (human),IC50, 7244.36
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 1052
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 374
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 68931
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 4893
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 25
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 139
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 127
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 371
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki,>10000
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 2522
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 128
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 374
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 206
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 272
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 92
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 469
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 303
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 9820
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 139
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 248
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 700
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 2522
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 350
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 195000
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 248
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 276
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 540
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 615
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 147
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,HTR3A,Mus musculus (house mouse),Ki,>10000
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 25224
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 303
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 257
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 20794
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 68.5
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine transporter,RAT,Ki, 367
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 48
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 272
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Voltage-gated potassium channel,Homo sapiens (human),IC50, 1202.26
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 6124
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 4129
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 181
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 248
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 67700
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 561
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 102
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 219
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 2420
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 149.4
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 6160
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 830
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki,>10000
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 89
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki,>10000
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 1190
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 30348
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 191
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 67700
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 28500
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 1230
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki,>10000
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 9
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 9057
Cocaine,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 143
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 8.32
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 1047.13
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Voltage-gated potassium channel,Homo sapiens (human),IC50, 120.23
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,DOPAMINE,RAT,Ki, 400
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 32.36
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 19
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki, 13.18
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,DRD2,BOVINE,IC50, 48
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Adrenergic alpha1B,Homo sapiens (Human),Ki, 691.83
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 1698.24
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 1.91
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Dopamine receptor,Rattus norvegicus (Rat),Ki, 0.62
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,DOPAMINE,RAT,IC50, 4340
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,HTR6,RAT,Ki, 29.9
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 7.8
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Alpha adrenergic receptor (1a and 1d),HUMAN,Ki, 295.12
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 4
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Kd, 4
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 53.2
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 2.3
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 7.08
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 1.8
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,5-hydroxytryptamine receptor 2A (5HT2A),Mus musculus (Mouse),EC50, 959
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 67.61
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,DRD2,BOVINE,IC50, 4180
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Dopamine D5 receptor,Homo sapiens (Human),Ki, 33.11
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Mu-type opioid receptor,Homo sapiens (human),EC50, 92470
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),IC50, 250
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 338.84
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki, 281.84
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Dopamine D2 receptor,Mus musculus (Mouse),Ki, 7.8
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 4
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,HTR7,GUINEA PIG,Ki, 2.95
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Beta-1 adrenergic receptor,Homo sapiens (human),Ki,>10000
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,DRD2,BOVINE,IC50, 7940
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Dopamine D1 receptor,Mus musculus (Mouse),Ki, 400
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 1
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 50.12
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 2020
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 14
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 295.12
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki,>10000
Pergolide,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,Serotonin (5-HT) receptor,Rattus norvegicus (rat),IC50, 260
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Serotonin (5-HT) receptor,Rattus norvegicus (rat),IC50, 310
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki,>10000
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 12.02
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 0.62
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 213.80
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),IC50, 11500
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),IC50, 570.0
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 6.17
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 19.95
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),EC50, 1.4
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,DOPAMINE,RAT,IC50,>10000
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 72.44
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 1.4
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 2.2
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),IC50, 1060
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 7.1
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki, 478.63
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki, 8.71
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Alpha adrenergic receptor (1a and 1d),HUMAN,Ki, 165.96
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Dopamine D5 receptor,Homo sapiens (Human),Ki, 22.39
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Serotonin (5-HT) receptor,Rattus norvegicus (rat),IC50, 210
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Beta-1 adrenergic receptor,Homo sapiens (human),Ki,>10000
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 1.17
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 691.83
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 22.39
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 1.000000
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 0.79
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),IC50, 50
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Adrenergic alpha1B,Homo sapiens (Human),Ki, 60.26
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 288.40
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,DOPAMINE,RAT,IC50, 850.0
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Serotonin (5-HT) receptor,Rattus norvegicus (rat),IC50, 90
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 1380.38
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 56.23
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,DOPAMINE,RAT,IC50,>10000
Cabergoline,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,Adrenergic receptor alpha,Rattus norvegicus (rat),Ki, 3.63
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 0.05
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 34.67
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki, 7.94
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 6918.31
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 64.57
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 0.34
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Histamine receptor (H4),Homo sapiens (human),Ki, 5012
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 0.15
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 0.5
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 0.74
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Kd, 0.30
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,HTR7,GUINEA PIG,Ki, 2.95
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 0.4
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Adrenergic receptor alpha,Rattus norvegicus (rat),Ki, 0.79
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 0.13
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 5.3
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 0.50
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki, 18.62
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 1.7
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki, 0.98
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Alpha adrenergic receptor (1a and 1d),HUMAN,Ki, 2.95
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Beta-1 adrenergic receptor,Homo sapiens (human),Ki, 67.61
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 77
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,OPIATE Sigma,RAT,Ki,>10000
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 0.28
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Dopamine D5 receptor,Homo sapiens (Human),Ki, 3.55
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 1.07
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Adrenergic alpha1B,Homo sapiens (Human),Ki, 16.60
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 5.88
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 1096.48
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 5.50
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 4.57
Lisuride,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,HTR6,RAT,Ki, 5.24
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 3.9
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Sigma,HUMAN,IC50, 48
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 301
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 8.5
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 54669.89
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,P-glycoprotein (P-gp),Mus musculus (Mouse),IC50,>50000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.14
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 3.2
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,GUINEA PIG,Ki, 1.9
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,MOUSE,Ki, 0.45
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),EC50, 7.3
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),EC50, 14
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.750000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,OPRD1,Bos taurus,Ki, 278
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Adrenergic Alpha,HUMAN,IC50, 28000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,MOUSE,EC50, 90
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Voltage-gated potassium channel,Homo sapiens (human),IC50, 1000000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 1.79
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 59138.22
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Cytochrome P450 3A,Homo sapiens (human),IC50,>50000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.480000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 49
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptor,MOUSE,IC50, 258
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),IC50, 100
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,GUINEA PIG,Ki, 63
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptor,Rattus norvegicus (rat),Ki, 0.6
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),IC50, 320
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.640000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 51
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),IC50, 1350
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Neuronal acetylcholine receptor,Rattus norvegicus (Rat),Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,CNR1,Hirudo medicinalis,Ki, 1000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 64.5
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 4260.21
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Vesicular acetylcholine transporter,Homo sapiens,IC50, 80000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.840000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.082000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),IC50, 10
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptor,Rattus norvegicus (rat),Ki, 0.13
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,GUINEA PIG,Ki, 1.5
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,MOUSE,Ki, 1.31
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin receptor,Cavia porcellus,Ki, 14
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu opioid receptor,CALF,Ki, 0.500000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),IC50, 440
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin receptor,Homo sapiens (human),Ki, 1270
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 3.02
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 5.1
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 5.5
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 22603.05
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 4.9
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 2.99
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 118.38
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),EC50, 4.9
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 120
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mas-related G protein-coupled receptor X2 (MRGPRX2),Homo sapiens (Human),EC50, 1.6e+4
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 15
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,OPRD1,Bos taurus,Ki, 63
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 4.8
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 43
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.160000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1.7
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 7
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Voltage-gated potassium channel,Homo sapiens (human),IC50, 301995.17
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,MOUSE,Ki, 1.5
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),EC50, 0.610000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,GUINEA PIG,Ki, 152
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.27
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 4.03
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki,>160000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 2.75
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptor,Rattus norvegicus (rat),Ki, 113
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),IC50,>9300
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,P-glycoprotein 1,Homo sapiens (Human),IC50,>50000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.13
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 22.8
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.670000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),IC50,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),IC50, 250
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 2891.36
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1.1
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 2400
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin receptor,Homo sapiens (human),Ki, 97
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.400000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.4
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 13
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mas-related G protein-coupled receptor X2 (MRGPRX2),Homo sapiens (Human),EC50, 6.2e+3
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),IC50, 50
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 3.2
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),IC50, 38
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,MOUSE,IC50,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,MOUSE,Ki, 1.41
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 5430
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 65.8
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.080000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.080000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin receptor,Homo sapiens (human),Ki, 34
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 65.5
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mas-related G protein-coupled receptor X2 (MRGPRX2),Homo sapiens (Human),EC50, 3.4e+3
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.6
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.050000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 230
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 1.8
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 5.4
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),IC50, 0.13
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.500000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,P-glycoprotein 1 and 3 (MDR1a/MDR1b),Mus musculus,IC50,>50000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Norepinephrine transporter,RAT,Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Cytochrome P450 2D2,Rattus norvegicus,IC50, 238000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,CNR1,theromyzon Tessulatum,Ki, 1000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1953
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 4410
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.700000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),IC50, 0.54
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),IC50, 1.3
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 674
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.2
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,MOUSE,Ki, 0.48
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 17700
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 108317.5
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mas-related G protein-coupled receptor X2 (MRGPRX2),Homo sapiens (Human),EC50, 6.8e+3
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),IC50, 0.11
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 44.5
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 16.3
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 104.57
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 2.1
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 24
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,GUINEA PIG,IC50, 530
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1821.51
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 5130
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,GUINEA PIG,Ki, 1
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.490000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.2
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.220000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.110000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,MOUSE,EC50, 1.99
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,OPIATE Kappa 3,CALF,Ki, 32.8
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 3.8
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.500000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 2427.13
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 4.0
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1.3
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptor,Rattus norvegicus (rat),Ki, 0.18
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 962
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki,>5000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 85.5
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 1.8
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.300000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 363
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Norepinephrine transporter,RAT,Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 45.5
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 11000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 740
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 420
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.8
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin receptor,Homo sapiens (human),Ki, 79
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,OPRD1,GUINEA PIG,Ki, 50
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.040000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),IC50, 95
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 5700
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu opioid receptor-like OR2,Danio rerio,Ki, 187
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.500000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 36000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 76000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,GUINEA PIG,IC50, 640
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 2800
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 72246.23
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.1
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),IC50, 6.4
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,MOUSE,Ki, 0.6
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.690000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 6.9
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.140000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.120000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),IC50, 7900
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.170000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.180000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.2
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1383.07
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 11.8
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 363
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),IC50, 15000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.160000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,"Cholinergic, muscarinic",RABBIT,Ki, 358
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.190000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.870000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),IC50, 650
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 14202.77
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),IC50, 230
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,MOUSE,Ki, 2.9
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 2
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.260000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mas-related G protein-coupled receptor X2 (MRGPRX2),Homo sapiens (Human),EC50, 1.2e+4
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),EC50, 559
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 8.44
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),IC50, 2.5
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.18
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1,Homo sapiens,IC50, 7001
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.3
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.380000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,OPRK1,Frog,Ki, 3.1
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 1.08
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin receptor,Homo sapiens (human),Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,MOUSE,EC50, 44
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),EC50, 14
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 3.9
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,MOUSE,Ki, 1
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),IC50, 105
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,MOUSE,Ki, 1.78
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.19
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mas-related G protein-coupled receptor X2 (MRGPRX2),Homo sapiens (Human),EC50, 1.9e+4
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki,>5000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 36539.78
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.500000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 420
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 5100
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),IC50, 520
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 9963.93
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.800000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.590000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu opioid receptor,CALF,Ki, 0.5
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 3.1
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),IC50, 1.2
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.27
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,MOUSE,Ki, 0.55
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.6
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Sigma,HUMAN,Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,MOUSE,Ki, 2.9
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 2.06
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Norepinephrine transporter,RAT,Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.32
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,OPRD1,GUINEA PIG,Ki, 19.3
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,OPRD1,GUINEA PIG,Ki, 60.5
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 14
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 2.7
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.880000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 78
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 4.6
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,"Nociceptin/Orphanin FQ, NOP receptor",MOUSE,Ki, 1000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.5
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),IC50, 100
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.180000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 160
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1.7
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 4297
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.7
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 217
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 96978.61
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),EC50, 2
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),EC50, 0.240000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,MOUSE,EC50, 11.9
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 11.1
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),IC50, 84
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),EC50, 0.660000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 1.02
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 2.3
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,GUINEA PIG,IC50, 0.480000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.97
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1.1
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.140000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,MOUSE,Ki, 1.45
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.8
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Cytochrome P450 2D1,Rattus norvegicus,IC50, 1320000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptor,Rattus norvegicus (rat),Ki, 5970
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Acetylcholinesterase,Electrophorus electricus (Electric eel),Ki, 109000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.080000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),IC50, 0.14
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 305
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptor,Rattus norvegicus (rat),Ki, 501
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.100000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.950000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin receptor,Homo sapiens (human),Ki, 197
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),IC50, 0.18
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 3.2
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 65
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Cytochrome P450 2D3,Rattus norvegicus,IC50, 4089000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1910
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,OPRD1,GUINEA PIG,Ki, 0.7
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Cytochrome P450 2D18,Rattus norvegicus,IC50, 2216000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 3.21
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.47
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Cytochrome P450 2D6 (2D6),Homo sapiens (Human),IC50, 104000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,MOUSE,Ki, 32.6
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,MOUSE,Ki, 0.88
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,GUINEA PIG,IC50, 0.750000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.320000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Nociceptin receptor,Homo sapiens (human),Ki, 187
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,GUINEA PIG,Ki, 3.9
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 4.2
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Delta-type opioid receptor,Homo sapiens (human),Ki, 11
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,GUINEA PIG,Ki, 53
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1.5
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 3090
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,OPRD1,GUINEA PIG,Ki,>10000
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mas-related G protein-coupled receptor X2 (MRGPRX2),Homo sapiens (Human),EC50, 5.5e+3
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,GUINEA PIG,Ki, 1.5
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,GUINEA PIG,IC50, 4500
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 28067
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,Mu-type opioid receptor,Homo sapiens (human),Ki, 9975.84
Morphine,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.800000
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.3
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,OPRD1,GUINEA PIG,Ki, 2.6
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,mu/kappa opioid receptor,GUINEA PIG,IC50, 0.500000
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Delta-type opioid receptor,Homo sapiens (human),Ki, 240
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 3.4
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.120000
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.440000
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),IC50, 9
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.210000
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Delta-type opioid receptor,Homo sapiens (human),Ki, 53
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.560000
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.3
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.3
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.240000
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.240000
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Opioid receptors; mu & delta,Rattus norvegicus (rat),IC50, 250
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),IC50, 2
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 1.8
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.29
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 143500
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 242800
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 2.6
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Kappa-type opioid receptor,Homo sapiens (human),Ki, 2.2
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.890000
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.190000
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),IC50, 13
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 2
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.480000
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Delta-type opioid receptor,Homo sapiens (human),Ki, 9.3
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Delta-type opioid receptor,Homo sapiens (human),Ki, 56
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.3
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Opioid receptors; mu & delta,Rattus norvegicus (rat),IC50, 110
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Delta-type opioid receptor,Homo sapiens (human),Ki, 79
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,mu/kappa opioid receptor,GUINEA PIG,IC50, 1.1
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Delta-type opioid receptor,Homo sapiens (human),Ki, 7.3
Nalmefene,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.3
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,OPRD1,GUINEA PIG,Ki, 4.2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki,>10000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 2.8
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.290000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.120000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 24800
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 13.98
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Ki, 55
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Kd, 50
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 24.7
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 0.72
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 26
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 4.8
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 13.3
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 80.5
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.54
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 10.6
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 38
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 48
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 4.8
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.310000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 11
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 5.57
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>10000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.9
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.120000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 28
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 24
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu opioid receptor,CALF,Ki, 3.3
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 880
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1400
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Kd, 1
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 14
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 46
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.0825
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1995
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 2.8
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 281
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 3.73
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,IC50, 9.70
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,IC50, 209
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.33
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Norepinephrine transporter,RAT,Ki,>10000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 13.3
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Ki, 22800
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.26
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.410000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 4.6
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 0.31
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 2.5
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1200
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 9.3
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 5.4
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.15
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.86
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Norepinephrine transporter,RAT,Ki,>10000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.3
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 36
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 304
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.09
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 3.67
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 32
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),IC50, 21
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 901
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 152
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.10
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),EC50,>10000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 35
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 1087
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),EC50, 9.8
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 14
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin receptor,Homo sapiens (human),Ki,>10000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,neuropeptides B/W receptor 1,Homo sapiens,Ki, 3000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 17.6
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1700
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.4
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki,>6000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 18
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 23
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 37
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 144
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Adenosine receptors; A1 & A2a,Homo sapiens (human),Ki,>50000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 39
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki,>7000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.300000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 9.45
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,OPRD1,GUINEA PIG,Ki, 13.5
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.7
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.810000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mas-related G protein-coupled receptor X2 (MRGPRX2),Homo sapiens (Human),EC50, 1.1e+4
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.047000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 26.3
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 74
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 28
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 164
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 294
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.70
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.010000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 19
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Acetylcholinesterase,Electrophorus electricus (Electric eel),IC50, 65300
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 1.9
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 66
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 25
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 2.4
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,"Nociceptin/Orphanin FQ, NOP receptor",MOUSE,Ki, 1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.430000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 33
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 272
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 0.330000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.130000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 125
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1700
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,"Nociceptin/Orphanin FQ, NOP receptor",MOUSE,Ki, 1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 2.46
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.97
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 25.2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.6
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 147
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 26.4
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Kd, 18
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.1
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,IC50, 63
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>3000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 0.5
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 41
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki,>10000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.240000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 3000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 86
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 3.2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.540000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,IC50, 30.5
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 57.6
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Angiotensin II receptor,Homo sapiens (Human),IC50, 14011
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 8.76
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.240000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 50.9
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 8.3
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 5.5
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.83
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 7.4
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 5.02
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.46
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.230000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 23
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Acetylcholinesterase,Electrophorus electricus (Electric eel),IC50, 140100
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 46200.0
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.34
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki,>3000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 6700
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 0.028000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.15
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.250000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 4.8
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.5
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.480000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 34
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.023
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,n-AChR,RAT,Ki,>10000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 41.8
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.190000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,OPIATE Sigma,RAT,Ki, 3500
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.66
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 3.7
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,IC50, 24.4
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Vesicular acetylcholine transporter,Homo sapiens,IC50,>100000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.1
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu/kappa/delta,Homo sapiens (human),Ki, 3.5
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Ki, 25.2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 133.48
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.61
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.18
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 39
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 8.69
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 6.1
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 7500
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 2.8
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 9.2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.4
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.280000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 118
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1.9
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Adenosine receptor A3,Homo sapiens (human),IC50, 1.6
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 6.5
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 10.3
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Acetylcholinesterase,Electrophorus electricus (Electric eel),IC50, 76200
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 43.60
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 9.2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 20.3
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 900
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 6.12
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 260
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 9.5
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,OPRD1,GUINEA PIG,Ki, 6.5
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.4
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 840
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 0.44
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 2.8
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Kd, 1.86
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,IC50, 0.8
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 1029
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.08
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,C-C chemokine receptor type 5,Mus musculus,Kd, 11
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,DRD1,BOVINE,Ki,>10000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>10000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 31
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,OPRK1,Frog,Ki, 0.9
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 5.18
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 182
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 33
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 3.9
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 0.0019
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 14.38
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 4.8
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 39
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 83.2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),IC50, 17
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 12.77
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Ki, 0.509
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 15
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 8.95
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 105500
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Neuronal acetylcholine receptor protein alpha-7 subunit,Homo sapiens (human),IC50, 25000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 4.05
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 1.4
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.8
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.25
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,apelin receptor,Homo sapiens,IC50, 3120
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.200000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.820000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 5.8
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu/kappa/delta,Homo sapiens (human),Ki, 13
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 102
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 2.14
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Cytochrome P450 2J2,Homo sapiens (Human),IC50,>50000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 1.25
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 119
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.37
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.930
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 5.1
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 33.8
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Kd, 0.400000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Neuronal acetylcholine receptor,Rattus norvegicus (Rat),IC50, 31000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.8
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.280000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 16.49
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Ki, 26.9
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 0.38
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.920
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 6.2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 3.14
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 880
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 5700
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 86
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 128
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.83
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 1.9
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 2.46
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 6.2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 2.92
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 840.0
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 33
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Norepinephrine transporter,RAT,Ki,>10000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 1.17
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.7
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 72.6
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 88
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,IC50, 2.3
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 6.6
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Kd, 20
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 25
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.170000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1.18
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 275
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 61.4
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),IC50,>1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 32.2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,"Cholinergic, muscarinic",RABBIT,Ki, 67.4
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 0.9
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 16
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki,>7200
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 193
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.560000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 16.31
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 7.8
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),EC50,>92384
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu/kappa/delta,Homo sapiens (human),Ki, 208
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 33.2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50,>1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 2000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),EC50, 87
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 200
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Ki, 95
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 5.9
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 16
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.81
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Sigma,HUMAN,Ki,>100000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 3.7
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 588
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.11
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opiate non-selective,GUINEA PIG,Ki, 1.4
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 30.3
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 610
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),IC50, 30
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 8.02
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.1
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 11
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 13
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 41
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50,>1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 20.14
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.490
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.340000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 7.38
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 5.36
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 40
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 8.81
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.410000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.070000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),IC50, 182
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,OPRD1,Bos taurus,Ki, 18.5
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 0.9
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 39
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 3.7
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 14
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 50
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.7
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki,>3000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1.4
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 19.92
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 10.2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,IC50, 1.5
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.09
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 3.3
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 3.7
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 13.3
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 8.6
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>10000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1.63
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 79
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Dopamine receptor,Rattus norvegicus (Rat),Ki,>20000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 5.01
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 10.2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.16
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 5.6
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Ki, 677
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 3.36
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1,Homo sapiens,IC50, 9735
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 68.4
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 5.34
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1400
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 3.99
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 0.646
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 1.5
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 3.8
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Ki, 2658
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 17
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 2
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 0.0041
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1.1
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 6.3
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.18
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.140000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1800
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki,>10000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 7.1
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.250000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.550000
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.12
Naltrexone,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,OPRD1,GUINEA PIG,Ki, 4.2
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki,>10000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 2.8
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.290000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.120000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 24800
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 13.98
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Ki, 55
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Kd, 50
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 24.7
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 0.72
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 26
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 4.8
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 180
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 13.3
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 80.5
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.54
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 10.6
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 38
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 48
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 4.8
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.310000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 11
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 5.57
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>10000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.9
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.120000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 28
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 16
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 24
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu opioid receptor,CALF,Ki, 3.3
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 880
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1400
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Kd, 1
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 14
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 46
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.0825
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1995
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 2.8
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 281
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 3.73
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,IC50, 9.70
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,IC50, 209
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Norepinephrine transporter,RAT,Ki,>10000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 13.3
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Ki, 22800
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.26
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.410000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 4.6
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 0.31
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 2.5
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1200
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 9.3
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 5.4
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.15
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.86
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Norepinephrine transporter,RAT,Ki,>10000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.3
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 36
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 304
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.09
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 3.67
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 32
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),IC50, 21
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 901
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 152
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.10
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),EC50,>10000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 35
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 1087
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),EC50, 9.8
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 14
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin receptor,Homo sapiens (human),Ki,>10000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,neuropeptides B/W receptor 1,Homo sapiens,Ki, 3000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 17.6
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1700
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.4
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki,>6000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 18
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 23
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 144
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Adenosine receptors; A1 & A2a,Homo sapiens (human),Ki,>50000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki,>7000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.300000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,OPRD1,GUINEA PIG,Ki, 13.5
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.7
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.810000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mas-related G protein-coupled receptor X2 (MRGPRX2),Homo sapiens (Human),EC50, 1.1e+4
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.047000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 26.3
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 28
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 2
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 294
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.010000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 19
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Acetylcholinesterase,Electrophorus electricus (Electric eel),IC50, 65300
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 1.9
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 66
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 25
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 2.4
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,"Nociceptin/Orphanin FQ, NOP receptor",MOUSE,Ki, 1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.430000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 33
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 272
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 0.330000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.130000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 125
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1700
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,"Nociceptin/Orphanin FQ, NOP receptor",MOUSE,Ki, 1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 2.46
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.97
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 25.2
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.6
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 147
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 26.4
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Kd, 18
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.1
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,IC50, 63
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>3000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 0.5
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 41
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki,>10000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 3000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 86
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 3.2
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.540000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,IC50, 30.5
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 57.6
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Angiotensin II receptor,Homo sapiens (Human),IC50, 14011
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 8.76
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 50.9
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 8.3
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 5.5
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.83
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 7.4
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 5.02
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.46
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.230000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Acetylcholinesterase,Electrophorus electricus (Electric eel),IC50, 140100
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 46200.0
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.2
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.34
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki,>3000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 6700
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 0.028000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.15
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.250000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 4.8
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.5
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.480000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 34
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.023
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,n-AChR,RAT,Ki,>10000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.2
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.190000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,OPIATE Sigma,RAT,Ki, 3500
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.66
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 3.7
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,IC50, 24.4
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Vesicular acetylcholine transporter,Homo sapiens,IC50,>100000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.1
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu/kappa/delta,Homo sapiens (human),Ki, 3.5
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Ki, 25.2
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 133.48
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.61
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.18
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 8.69
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 6.1
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 7500
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 2.8
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 9.2
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.4
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.280000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 118
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1.9
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Adenosine receptor A3,Homo sapiens (human),IC50, 1.6
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 6.5
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 10.3
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Acetylcholinesterase,Electrophorus electricus (Electric eel),IC50, 76200
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 43.60
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 9.2
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 20.3
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 900
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 6.12
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 260
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 9.5
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,OPRD1,GUINEA PIG,Ki, 6.5
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.4
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 840
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 0.44
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 2.8
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Kd, 1.86
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,IC50, 0.8
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 1029
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.08
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,C-C chemokine receptor type 5,Mus musculus,Kd, 11
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,DRD1,BOVINE,Ki,>10000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>10000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 31
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,OPRK1,Frog,Ki, 0.9
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 5.18
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 182
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 33
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 3.9
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 0.0019
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 14.38
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 4.8
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 39
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 83.2
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),IC50, 17
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Ki, 0.509
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 15
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 8.95
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 105500
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Neuronal acetylcholine receptor protein alpha-7 subunit,Homo sapiens (human),IC50, 25000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 4.05
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 1.4
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.25
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,apelin receptor,Homo sapiens,IC50, 3120
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.200000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.820000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu/kappa/delta,Homo sapiens (human),Ki, 13
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 102
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 2.14
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Cytochrome P450 2J2,Homo sapiens (Human),IC50,>50000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 1.25
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 119
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.37
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.930
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 5.1
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 33.8
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Kd, 0.400000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Neuronal acetylcholine receptor,Rattus norvegicus (Rat),IC50, 31000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.8
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.280000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Ki, 26.9
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 0.38
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.920
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 6.2
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 3.14
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 5700
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 51
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 86
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 128
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.83
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 1.9
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 2.46
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 6.2
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 2.92
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 840.0
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 33
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Norepinephrine transporter,RAT,Ki,>10000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 1.17
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 72.6
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 88
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,IC50, 2.3
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 6.6
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Kd, 20
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 25
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.170000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1.18
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 275
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 61.4
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),IC50,>1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 32.2
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,"Cholinergic, muscarinic",RABBIT,Ki, 67.4
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 0.9
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 16
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki,>7200
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 193
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.560000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 16.31
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 7.8
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),EC50,>92384
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu/kappa/delta,Homo sapiens (human),Ki, 208
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 33.2
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50,>1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 2000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),EC50, 87
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 200
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Ki, 95
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 5.9
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.81
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Sigma,HUMAN,Ki,>100000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 3.7
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 588
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.11
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opiate non-selective,GUINEA PIG,Ki, 1.4
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 30.3
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 610
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),IC50, 30
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 8.02
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.1
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 13
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 41
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50,>1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 20.14
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.490
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.340000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 7.38
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 5.36
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 40
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 8.81
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.410000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.070000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),IC50, 182
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,OPRD1,Bos taurus,Ki, 18.5
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 0.9
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 39
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 3.7
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 14
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 50
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.7
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki,>3000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1.4
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 19.92
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 10.2
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,IC50, 1.5
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.09
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 3.3
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 3.7
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 13.3
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 8.6
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>10000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1.63
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Dopamine receptor,Rattus norvegicus (Rat),Ki,>20000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 5.01
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 10.2
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.16
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Ki, 677
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,Ki, 3.36
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1,Homo sapiens,IC50, 9735
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 68.4
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 5.34
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1400
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,MOUSE,Ki, 0.646
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,GUINEA PIG,IC50, 1.5
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 3.8
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Opioid receptor,Rattus norvegicus (rat),Ki, 2658
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 17
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 2
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,MOUSE,Ki, 0.0041
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1.1
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 6.3
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.18
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.140000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1800
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki,>10000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 7.1
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.250000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.550000
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.12
Oxycodone,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>1000
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,DRD2,RABBIT,Ki, 2.7
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,DRD2,BOVINE,Ki, 0.98
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,ubiquitin-conjugating enzyme E2 N,Homo sapiens,IC50,>20000
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,adrenergic Alpha2,RAT,Ki, 5.4
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,DRD1,CANINE,Ki, 30
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Twik-RElated Potassium (K+) channel 1 (TREK1),Homo sapiens (Human),EC50, 2000
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 0.6
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,HTR3A,Mus musculus (house mouse),Ki,>10000
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Adrenergic Alpha,HUMAN,IC50, 89500
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 8028
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 13
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Twik-RElated Potassium (K+) channel 1 (TREK1),Homo sapiens (Human),IC50, 2000
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Dopamine receptor,Rattus norvegicus (Rat),Ki, 3.25
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Sigma,HUMAN,IC50, 2.2
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 0.3
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 0.34
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 0.6
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,DOPAMINE,RAT,IC50, 0.300000
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 1.6
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Dopamine D5 receptor,Homo sapiens (Human),Ki, 8
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 102
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 3
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Dopamine D2 receptor,Mus musculus (Mouse),Ki, 0.34
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Dopamine D1 receptor,Mus musculus (Mouse),Ki, 0.32
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,DOPAMINE,RAT,Ki, 0.32
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 131
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Dopamine D1B,RAT,Ki, 7
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 2
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,DRD1,BOVINE,Ki, 3.16
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 0.2
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Sigma,HUMAN,IC50, 15
Flupentixol,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 0.25
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,trace amine-associated receptor 1,Homo sapiens,EC50, 5470
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 6606
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 34
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 7.1
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Cytochrome P450 2A5,Mus musculus,IC50, 2850
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Phenylethanolamine N-methyltransferase,Bos taurus (bovine),Ki,>1000000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki,>10000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,HTR3A,Mus musculus (house mouse),Ki,>10000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Sigma,HUMAN,Ki, 46400
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,SLC6A4,MOUSE,IC50, 45000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Monoamine oxidase,Bos taurus,Ki, 380000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,OPIATE Sigma,RAT,Ki,>10000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki,>10000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),EC50, 24.8
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Monoamine oxidase,Rattus norvegicus (rat),Ki, 12200
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki,>10000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki,>10000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Monoamine oxidase,Bos taurus,Ki, 300000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,adrenergic Alpha2,RAT,Ki, 992
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Phenylethanolamine N-methyltransferase,Bos taurus (bovine),Ki, 422000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Trace amine-associated receptor 1,Macaca mulatta,EC50, 1860
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Transporter,Rattus norvegicus (rat),IC50, 200
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Serotonin receptor 2a and 2b (5HT2A and 5HT2B),RAT,Kd, 5370.32
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki,>10000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Phenylethanolamine N-methyltransferase,Bos taurus (bovine),Ki, 740000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Trace amine-associated receptor 1,Macaca mulatta,EC50, 1010
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Trace amine-associated receptor 1 (TAAR1),Rattus norvegicus (Rat),EC50, 210
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 1400
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),EC50, 1770
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Trace amine-associated receptor 1 (TAAR1),Rattus norvegicus (Rat),EC50, 440
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 1250
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,trace amine-associated receptor 1,Homo sapiens,EC50, 140
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 1600
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Trace amine-associated receptor 1 (TAAR1),Mus musculus (Mouse),EC50, 65
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Monoamine Oxidase Type B (MAO-B),Rattus norvegicus (rat),Ki, 160000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 24.8
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Monoamine Oxidase Type B (MAO-B),Rattus norvegicus (rat),Ki, 180000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,trace amine-associated receptor 1,Homo sapiens,EC50, 250
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Phenylethanolamine N-methyltransferase,Bos taurus (bovine),Ki, 1381000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki,>10000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),EC50, 7.1
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>10000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Norepinephrine transporter,RAT,Ki, 244
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki,>10000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Trace amine-associated receptor 1 (TAAR1),Mus musculus (Mouse),EC50, 2
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Norepinephrine transporter,RAT,Ki, 38.9
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Norepinephrine transporter,MOUSE,IC50, 1000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Cytochrome P450 2A6,Homo sapiens (Human),IC50, 3500
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 1000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki,>10000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki,>10000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 1580
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki,>10000
Dextroamphetamine,C[C@H](N)CC1=CC=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 4900
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>7000
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,HTR1D,Bos taurus (Bovine),Ki, 6300
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki, 0.114000
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Kd, 0.537032
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,HTR3A,pigeon,Ki, 6610
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,5-HT5B,RAT,Ki, 1000
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Serotonin (5-HT) receptor,HUMAN,Ki,>10000
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki,>10000
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,HTR2C,pigeon,Ki,>10000
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 9332.54
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,DRD3,pigeon,Ki,>10000
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 26
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 11
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Beta-1 adrenergic receptor,Homo sapiens (human),Ki, 2.4
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,HTR7,GUINEA PIG,Ki, 501.19
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,HTR1B,pigeon,Ki, 1200
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki,>10000
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 24
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,5-hydroxytryptamine receptor 1B (5HT1B),Mus musculus (Mouse),Ki, 63.09
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki, 4900
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 20
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Serotonin 1B/1D receptor,Rattus norvegicus (Rat),Ki, 24
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,5-HT5,MOUSE,Ki,>10000
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 15
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki, 3.8
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,HTR2A,pigeon,Ki,>10000
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 3.6
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Serotonin (5-HT) receptor,Homo sapiens,Ki,>10000
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Beta-3 adrenergic receptor,Homo sapiens (human),Kd, 166
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 2187.76
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 110
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 29
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki, 2600
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 1.3
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Beta-1 adrenergic receptor,GUINEA PIG,Ki, 7.24
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Beta-2 adrenergic receptor,GUINEA PIG,Ki, 1.14
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,HTR6,MOUSE,Ki,>10000
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki,>10000
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,HTR1D,pigeon,Ki,>10000
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,DRD2,pigeon,Ki,>10000
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,adrenergic Alpha1,pigeon,Ki, 7585
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Adrenergic receptor beta,Rattus norvegicus (Rat),Ki, 0.66
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,HTR1A,pigeon,Ki, 47
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Beta-1 adrenergic receptor,Homo sapiens (human),Kd, 2.4
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki,>10000
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,ADRB2,Rattus norvegicus,Ki, 0.32
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki,>7000
Amphetamine,CC(N)CC1=CC=CC=C1,trace amine-associated receptor 1,Homo sapiens,EC50, 5470
Amphetamine,CC(N)CC1=CC=CC=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 6606
Amphetamine,CC(N)CC1=CC=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 34
Amphetamine,CC(N)CC1=CC=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 7.1
Amphetamine,CC(N)CC1=CC=CC=C1,Cytochrome P450 2A5,Mus musculus,IC50, 2850
Amphetamine,CC(N)CC1=CC=CC=C1,Phenylethanolamine N-methyltransferase,Bos taurus (bovine),Ki,>1000000
Amphetamine,CC(N)CC1=CC=CC=C1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki,>10000
Amphetamine,CC(N)CC1=CC=CC=C1,HTR3A,Mus musculus (house mouse),Ki,>10000
Amphetamine,CC(N)CC1=CC=CC=C1,Sigma,HUMAN,Ki, 46400
Amphetamine,CC(N)CC1=CC=CC=C1,SLC6A4,MOUSE,IC50, 45000
Amphetamine,CC(N)CC1=CC=CC=C1,Monoamine oxidase,Bos taurus,Ki, 380000
Amphetamine,CC(N)CC1=CC=CC=C1,OPIATE Sigma,RAT,Ki,>10000
Amphetamine,CC(N)CC1=CC=CC=C1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki,>10000
Amphetamine,CC(N)CC1=CC=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),EC50, 24.8
Amphetamine,CC(N)CC1=CC=CC=C1,Monoamine oxidase,Rattus norvegicus (rat),Ki, 12200
Amphetamine,CC(N)CC1=CC=CC=C1,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki,>10000
Amphetamine,CC(N)CC1=CC=CC=C1,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki,>10000
Amphetamine,CC(N)CC1=CC=CC=C1,Monoamine oxidase,Bos taurus,Ki, 300000
Amphetamine,CC(N)CC1=CC=CC=C1,adrenergic Alpha2,RAT,Ki, 992
Amphetamine,CC(N)CC1=CC=CC=C1,Phenylethanolamine N-methyltransferase,Bos taurus (bovine),Ki, 422000
Amphetamine,CC(N)CC1=CC=CC=C1,Trace amine-associated receptor 1,Macaca mulatta,EC50, 1860
Amphetamine,CC(N)CC1=CC=CC=C1,Transporter,Rattus norvegicus (rat),IC50, 200
Amphetamine,CC(N)CC1=CC=CC=C1,Serotonin receptor 2a and 2b (5HT2A and 5HT2B),RAT,Kd, 5370.32
Amphetamine,CC(N)CC1=CC=CC=C1,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki,>10000
Amphetamine,CC(N)CC1=CC=CC=C1,Phenylethanolamine N-methyltransferase,Bos taurus (bovine),Ki, 740000
Amphetamine,CC(N)CC1=CC=CC=C1,Trace amine-associated receptor 1,Macaca mulatta,EC50, 1010
Amphetamine,CC(N)CC1=CC=CC=C1,Trace amine-associated receptor 1 (TAAR1),Rattus norvegicus (Rat),EC50, 210
Amphetamine,CC(N)CC1=CC=CC=C1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 1400
Amphetamine,CC(N)CC1=CC=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),EC50, 1770
Amphetamine,CC(N)CC1=CC=CC=C1,Trace amine-associated receptor 1 (TAAR1),Rattus norvegicus (Rat),EC50, 440
Amphetamine,CC(N)CC1=CC=CC=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 1250
Amphetamine,CC(N)CC1=CC=CC=C1,trace amine-associated receptor 1,Homo sapiens,EC50, 140
Amphetamine,CC(N)CC1=CC=CC=C1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 1600
Amphetamine,CC(N)CC1=CC=CC=C1,Trace amine-associated receptor 1 (TAAR1),Mus musculus (Mouse),EC50, 65
Amphetamine,CC(N)CC1=CC=CC=C1,Monoamine Oxidase Type B (MAO-B),Rattus norvegicus (rat),Ki, 160000
Amphetamine,CC(N)CC1=CC=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 24.8
Amphetamine,CC(N)CC1=CC=CC=C1,Monoamine Oxidase Type B (MAO-B),Rattus norvegicus (rat),Ki, 180000
Amphetamine,CC(N)CC1=CC=CC=C1,trace amine-associated receptor 1,Homo sapiens,EC50, 250
Amphetamine,CC(N)CC1=CC=CC=C1,Phenylethanolamine N-methyltransferase,Bos taurus (bovine),Ki, 1381000
Amphetamine,CC(N)CC1=CC=CC=C1,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki,>10000
Amphetamine,CC(N)CC1=CC=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),EC50, 7.1
Amphetamine,CC(N)CC1=CC=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>10000
Amphetamine,CC(N)CC1=CC=CC=C1,Norepinephrine transporter,RAT,Ki, 244
Amphetamine,CC(N)CC1=CC=CC=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki,>10000
Amphetamine,CC(N)CC1=CC=CC=C1,Trace amine-associated receptor 1 (TAAR1),Mus musculus (Mouse),EC50, 2
Amphetamine,CC(N)CC1=CC=CC=C1,Norepinephrine transporter,RAT,Ki, 38.9
Amphetamine,CC(N)CC1=CC=CC=C1,Norepinephrine transporter,MOUSE,IC50, 1000
Amphetamine,CC(N)CC1=CC=CC=C1,Cytochrome P450 2A6,Homo sapiens (Human),IC50, 3500
Amphetamine,CC(N)CC1=CC=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 1000
Amphetamine,CC(N)CC1=CC=CC=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki,>10000
Amphetamine,CC(N)CC1=CC=CC=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki,>10000
Amphetamine,CC(N)CC1=CC=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 1580
Amphetamine,CC(N)CC1=CC=CC=C1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki,>10000
Amphetamine,CC(N)CC1=CC=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 4900
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 5920
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 793
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 570
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 4133
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 2214
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 5400
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),EC50, 181
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 3420
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Norepinephrine transporter,RAT,Ki, 940
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,DOPAMINE,RAT,Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 1800
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Homo sapiens (Human),IC50,>100
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Neuronal acetylcholine receptor protein alpha-7 subunit,Homo sapiens (human),IC50, 7900
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 2200
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),EC50, 356
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 441
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Cytochrome P450 2B6,Homo sapiens (Human),IC50, 19200
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 592
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Uridine-5&#39;-diphosphoglucuronosyltransferase 1A4,Homo sapiens (Human),IC50, 1.52e+5
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),EC50, 733
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 459
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Acetylcholine receptor protein alpha chain/beta chain/delta chain /gamma chain,Homo sapiens (Human),IC50, 79
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Muscarinic receptor M2 and M3,RAT,Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Homo sapiens (Human),IC50, 12
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Homo sapiens (Human),IC50,>100
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Uridine-5&#39;-diphosphoglucuronosyltransferase 2B7,Homo sapiens (Human),IC50,>3.00e+5
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 4000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 369
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 425
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 1150
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,n-AChR,RAT,Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Homo sapiens (Human),IC50, 8.6
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 4200
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 9100
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Uridine-5&#39;-diphosphoglucuronosyltransferase 1A1,Homo sapiens (Human),IC50,>3.00e+5
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 3180
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Histamine H1 receptor,RAT,Ki, 29
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,ADRB2,Rattus norvegicus,Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Homo sapiens (Human),IC50, 9.2
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 3090
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 4476
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,adrenergic Alpha2,RAT,Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Neuronal acetylcholine receptor protein alpha-3/beta-4 subunit,HUMAN,IC50, 18
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Adrenergic receptor beta,Rattus norvegicus (Rat),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 472
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),EC50, 410
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Neuronal acetylcholine receptor protein alpha-3/beta-2 subunit,Homo sapiens (Human),IC50, 1000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 343
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 533
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 2100
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 3980
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Uridine-5&#39;-diphosphoglucuronosyltransferase 2B10,Homo sapiens (Human),IC50, 8.8e+4
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Homo sapiens (Human),IC50, 29
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),EC50, 47
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 5700
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 6970
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),EC50, 562
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 6400
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Histamine H1 receptor,Homo sapiens (human),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,CHRM5,Homo sapiens,Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 1480
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 3195
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Homo sapiens (Human),IC50, 19
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 1000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 3450
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-4 subunit,HUMAN,IC50, 12
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Uridine-5&#39;-diphosphoglucuronosyltransferase 1A6,Homo sapiens (Human),IC50,>3.00e+5
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 1150
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Homo sapiens (Human),IC50,>100
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki,>10000
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 5100
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 294
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki,>10000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,HTR7,GUINEA PIG,Ki, 0.40
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,DOPAMINE,RAT,Ki, 21
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,5-hydroxytryptamine receptor 7 (5HT7),Mus musculus (Mouse),Ki, 1.3
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,HTR2C,PIG,Ki, 47
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki,>5000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Transporter,Rattus norvegicus (rat),Ki, 28000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Voltage-gated sodium channel subunit Nav1.5,Homo sapiens (Human),IC50, 25119
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 30
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Norepinephrine transporter,RAT,Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 0.14
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 2.3
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Serotonin (5-HT) receptor,Homo sapiens,Ki, 1320
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Voltage-gated potassium channel,Homo sapiens (human),IC50, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Solute carrier family 22 member 2,Homo sapiens,IC50, 11000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Dopamine receptor,Rattus norvegicus (Rat),Ki, 7.5
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki, 5000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 48
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Adrenergic receptor alpha-1,Homo sapiens (Human),Ki, 2.3
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,"Cholinergic, muscarinic",RABBIT,Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 4.3
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 2800
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Voltage-gated sodium channel subunit alpha Nav1.8,Rattus norvegicus (Rat),Ki, 5000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 3.5
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,"1,3-beta-glucan synthase component GLS2",Saccharomyces cerevisiae,IC50, 1070
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Adrenergic receptor alpha,Rattus norvegicus (rat),Ki, 25
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Calcium channel,RAT,Ki, 5000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,CHRM5,Homo sapiens,Ki,>10000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Dopamine receptor,RAT,Ki, 7.5
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 8.5
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Muscarinic receptor M2 and M3,RAT,Ki, 5000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 0.69
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 0.3
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 0.43
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,HTR6,RAT,Ki, 420
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki, 3.9
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,NT,GUINEA PIG,Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Cholecystokinin B,GUINEA PIG,Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 10.1
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,"Cholinergic, muscarinic",RABBIT,Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 950
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Serotonin (5-HT) receptor,Homo sapiens,Ki, 1020
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 21
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,DRD2,GUINEA PIG,Ki, 0.83
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,DOPAMINE,RAT,Ki, 510
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 10
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Multidrug and toxin extrusion protein 1,Homo sapiens,IC50, 1600
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 1460
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Serum albumin,Rattus norvegicus,Kd, 4.4
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Norepinephrine transporter,RAT,Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,HTR1D,Bos taurus (Bovine),Ki, 117
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 9.4
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki, 19
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Histamine H1 receptor,Homo sapiens (human),Ki, 2.6
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,HTR3A,Mus musculus (house mouse),Ki, 5000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Prostanoid TP receptor,Homo sapiens (Human),Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Adrenergic receptor alpha-2,Homo sapiens (Human),Ki, 7.5
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 1
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Voltage-dependent L-type calcium channel subunit alpha-1C,Cavia porcellus,IC50, 73000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Serotonin (5-HT) receptor,Rattus norvegicus (Rat),Ki, 30
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Calcium channel (Type L),HUMAN,IC50, 125000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Adrenergic receptor beta,Rattus norvegicus (Rat),Ki, 22000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,CCKBR,RAT,Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 0.25
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 1.6
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Dopamine receptor,Rattus norvegicus (Rat),Ki, 2.8
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,adrenergic Alpha2,RAT,Ki, 1.8
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Calcium channel (Type L),HUMAN,IC50, 398107
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Voltage-gated potassium channel subunit Kv4.3,Homo sapiens,IC50, 63096
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 0.44
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Serotonin receptor 2a and 2b (5HT2A and 5HT2B),RAT,Ki, 203
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 29.2
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 480
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Histamine H1 receptor,RAT,Ki, 88
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Muscarinic receptor M2 and M3,RAT,Ki, 3570
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Histamine H1 receptor,Homo sapiens (human),Ki, 3.4
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 0.22
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 1.3
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Serotonin 1B/1D receptor,Rattus norvegicus (Rat),Ki, 3250
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Voltage-gated sodium channel subunit alpha Nav1.8,Rattus norvegicus (Rat),Ki, 3860
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Dopamine D5 receptor,Homo sapiens (Human),Ki, 563
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Prostanoid TP receptor,Homo sapiens (Human),Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Sigma,HUMAN,Ki, 4300
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,5-hydroxytryptamine receptor 1A (5HT1A),Mus musculus (Mouse),IC50, 430
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 0.1
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 30
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki, 9.8
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 224
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 2900
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Substance P,HUMAN,Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,HTR1D,Bos taurus (Bovine),Ki, 60
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 21
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Norepinephrine Monoamine transporters,Rattus norvegicus,Ki,>5454
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Glycine,na,EC50, 320
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 6.4
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Dopamine D2 receptor,Mus musculus (Mouse),IC50, 23
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Substance P,HUMAN,Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Serotonin (5-HT) receptor,HUMAN,Ki, 1240
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,ADRA1B,PIG,Ki, 3.16
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Cysteinyl leukotriene receptor 1,GUINEA PIG,Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 11
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,HTR2C,PIG,Ki, 48
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 3700
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 2.6
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Beta-1 adrenergic receptor,Homo sapiens (human),Ki, 5000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,ADRA1A,PIG,Ki, 0.50
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,adrenergic Alpha2,RAT,Ki, 17
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,CCKBR,RAT,Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Voltage-gated potassium channel beta subunit Mink/subunit Kv7.1,Homo sapiens,IC50, 251189
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,HTR3A,Mus musculus (house mouse),Ki, 5000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Histone H1,Homo sapiens (Human),Ki, 14
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki, 12
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 8
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,5-hydroxytryptamine receptor 7 (5HT7),Mus musculus (Mouse),Ki, 1.6
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Multidrug and toxin extrusion protein 2,Homo sapiens,IC50, 291000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Calcium channel,RAT,Ki, 5000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Delta-type opioid receptor,MOUSE,Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 4
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 0.016
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 8800
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Serotonin 1B/1D receptor,Rattus norvegicus (Rat),Ki, 1325
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Voltage-gated sodium channel subunit Nav1.5,Homo sapiens (Human),IC50, 102000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,NT,GUINEA PIG,Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki, 5000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Delta-type opioid receptor,MOUSE,Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Voltage-gated potassium channel,Homo sapiens (human),Ki, 167
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 6.4
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Cholecystokinin B,GUINEA PIG,Ki, 1000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Beta-1 adrenergic receptor,Homo sapiens (human),Ki, 5000
Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Cysteinyl leukotriene receptor 1,GUINEA PIG,Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,HTR7,GUINEA PIG,Ki, 0.40
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,DOPAMINE,RAT,Ki, 21
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,5-hydroxytryptamine receptor 7 (5HT7),Mus musculus (Mouse),Ki, 1.3
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,HTR2C,PIG,Ki, 47
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki,>5000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Transporter,Rattus norvegicus (rat),Ki, 28000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Voltage-gated sodium channel subunit Nav1.5,Homo sapiens (Human),IC50, 25119
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 30
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Norepinephrine transporter,RAT,Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 0.14
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 2.3
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Serotonin (5-HT) receptor,Homo sapiens,Ki, 1320
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Voltage-gated potassium channel,Homo sapiens (human),IC50, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Solute carrier family 22 member 2,Homo sapiens,IC50, 11000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Dopamine receptor,Rattus norvegicus (Rat),Ki, 7.5
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki, 5000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 48
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Adrenergic receptor alpha-1,Homo sapiens (Human),Ki, 2.3
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,"Cholinergic, muscarinic",RABBIT,Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 4.3
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 2800
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Voltage-gated sodium channel subunit alpha Nav1.8,Rattus norvegicus (Rat),Ki, 5000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 3.5
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,"1,3-beta-glucan synthase component GLS2",Saccharomyces cerevisiae,IC50, 1070
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Adrenergic receptor alpha,Rattus norvegicus (rat),Ki, 25
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Calcium channel,RAT,Ki, 5000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,CHRM5,Homo sapiens,Ki,>10000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Dopamine receptor,RAT,Ki, 7.5
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 8.5
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Muscarinic receptor M2 and M3,RAT,Ki, 5000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 0.69
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 0.3
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 0.43
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,HTR6,RAT,Ki, 420
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki, 3.9
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,NT,GUINEA PIG,Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Cholecystokinin B,GUINEA PIG,Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 10.1
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,"Cholinergic, muscarinic",RABBIT,Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 950
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Serotonin (5-HT) receptor,Homo sapiens,Ki, 1020
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 21
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,DRD2,GUINEA PIG,Ki, 0.83
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,DOPAMINE,RAT,Ki, 510
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 10
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Multidrug and toxin extrusion protein 1,Homo sapiens,IC50, 1600
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 1460
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Serum albumin,Rattus norvegicus,Kd, 4.4
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Norepinephrine transporter,RAT,Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,HTR1D,Bos taurus (Bovine),Ki, 117
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 9.4
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki, 19
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Histamine H1 receptor,Homo sapiens (human),Ki, 2.6
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,HTR3A,Mus musculus (house mouse),Ki, 5000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Prostanoid TP receptor,Homo sapiens (Human),Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Adrenergic receptor alpha-2,Homo sapiens (Human),Ki, 7.5
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 1
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Voltage-dependent L-type calcium channel subunit alpha-1C,Cavia porcellus,IC50, 73000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Serotonin (5-HT) receptor,Rattus norvegicus (Rat),Ki, 30
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Calcium channel (Type L),HUMAN,IC50, 125000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Adrenergic receptor beta,Rattus norvegicus (Rat),Ki, 22000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,CCKBR,RAT,Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 0.25
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 1.6
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Dopamine receptor,Rattus norvegicus (Rat),Ki, 2.8
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,adrenergic Alpha2,RAT,Ki, 1.8
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Calcium channel (Type L),HUMAN,IC50, 398107
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Voltage-gated potassium channel subunit Kv4.3,Homo sapiens,IC50, 63096
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 0.44
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Serotonin receptor 2a and 2b (5HT2A and 5HT2B),RAT,Ki, 203
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 29.2
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 480
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Histamine H1 receptor,RAT,Ki, 88
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Muscarinic receptor M2 and M3,RAT,Ki, 3570
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Histamine H1 receptor,Homo sapiens (human),Ki, 3.4
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 0.22
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 1.3
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Serotonin 1B/1D receptor,Rattus norvegicus (Rat),Ki, 3250
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Voltage-gated sodium channel subunit alpha Nav1.8,Rattus norvegicus (Rat),Ki, 3860
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Dopamine D5 receptor,Homo sapiens (Human),Ki, 563
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Prostanoid TP receptor,Homo sapiens (Human),Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Sigma,HUMAN,Ki, 4300
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,5-hydroxytryptamine receptor 1A (5HT1A),Mus musculus (Mouse),IC50, 430
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 0.1
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 30
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki, 9.8
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 224
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 2900
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Substance P,HUMAN,Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,HTR1D,Bos taurus (Bovine),Ki, 60
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 21
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Norepinephrine Monoamine transporters,Rattus norvegicus,Ki,>5454
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Glycine,na,EC50, 320
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 6.4
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Dopamine D2 receptor,Mus musculus (Mouse),IC50, 23
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Substance P,HUMAN,Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Serotonin (5-HT) receptor,HUMAN,Ki, 1240
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,ADRA1B,PIG,Ki, 3.16
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Cysteinyl leukotriene receptor 1,GUINEA PIG,Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 11
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,HTR2C,PIG,Ki, 48
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 3700
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 2.6
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Beta-1 adrenergic receptor,Homo sapiens (human),Ki, 5000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,ADRA1A,PIG,Ki, 0.50
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,adrenergic Alpha2,RAT,Ki, 17
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,CCKBR,RAT,Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Voltage-gated potassium channel beta subunit Mink/subunit Kv7.1,Homo sapiens,IC50, 251189
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,HTR3A,Mus musculus (house mouse),Ki, 5000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Histone H1,Homo sapiens (Human),Ki, 14
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki, 12
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 8
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,5-hydroxytryptamine receptor 7 (5HT7),Mus musculus (Mouse),Ki, 1.6
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Multidrug and toxin extrusion protein 2,Homo sapiens,IC50, 291000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Calcium channel,RAT,Ki, 5000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Delta-type opioid receptor,MOUSE,Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 4
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 0.016
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 8800
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Serotonin 1B/1D receptor,Rattus norvegicus (Rat),Ki, 1325
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Voltage-gated sodium channel subunit Nav1.5,Homo sapiens (Human),IC50, 102000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,NT,GUINEA PIG,Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki, 5000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Delta-type opioid receptor,MOUSE,Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Voltage-gated potassium channel,Homo sapiens (human),Ki, 167
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 6.4
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Cholecystokinin B,GUINEA PIG,Ki, 1000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Beta-1 adrenergic receptor,Homo sapiens (human),Ki, 5000
Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Cysteinyl leukotriene receptor 1,GUINEA PIG,Ki, 1000
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Serotonin (5-HT) receptor,Homo sapiens (Human),Ki, 220
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 15
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 44
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Serotonin 3 (5-HT3) receptor,Homo sapiens (Human),Ki, 56
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Serotonin 3 (5-HT3) receptor,Homo sapiens (Human),Ki, 3.7
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Serotonin (5-HT) receptor,RAT,Ki, 230
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Histamine H1 receptor,Homo sapiens (human),Ki, 180
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Serotonin 3 (5-HT3) receptor,Homo sapiens (Human),Ki, 670
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 25
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 18
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 540
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Serotonin 3 (5-HT3) receptor,Homo sapiens (Human),Ki, 150
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 2700
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 110
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 1400
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Serotonin 3 (5-HT3) receptor,Homo sapiens (Human),Ki, 45
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 330
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 5.3
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Cytochrome P450 2D6 (2D6),Homo sapiens (Human),IC50, 2700
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 540
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Cytochrome P450 2D6 (2D6),Homo sapiens (Human),IC50, 9800
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki, 33
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Histamine H2 Receptor,Homo sapiens (human),Ki, 180
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Serotonin 3 (5-HT3) receptor,Homo sapiens (Human),Ki, 32
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 51
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 890
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 14
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Beta-1 adrenergic receptor,Homo sapiens (human),Ki, 46
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Cytochrome P450 2C9,Homo sapiens (human),IC50, 40000
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Cytochrome P450 2C9,Homo sapiens (human),IC50, 39000
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Cytochrome P450 3A,Homo sapiens (human),IC50, 10000
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Cytochrome P450 1A,Homo sapiens (human),IC50, 40000
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Cytochrome P450 3A,Homo sapiens (human),IC50, 16000
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Cytochrome P450 1A,Homo sapiens (human),IC50, 40000
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 180
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki, 560
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 180
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 1.6
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 680
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 19
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 200
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Serotonin 3 (5-HT3) receptor,Homo sapiens (Human),Ki, 130
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 120
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,Cholecystokinin receptor,Homo sapiens (human),IC50,>100000
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,GABA A Alpha2Beta1Gamma2,Homo sapiens (Human),Ki, 1.2
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,Platelet activating factor receptor,HUMAN,Ki, 2610
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,GABA receptor alpha-6/beta-3/gamma-2 subunit,HUMAN,Ki,>10000
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,GABA A receptor alpha-3/beta-2/gamma-2,HUMAN,EC50, 69
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,GABA receptor alpha-1/beta-3/gamma-2 subunit,Homo sapiens (Human),Ki, 0.80
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 0.31
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,Cholecystokinin receptor,Homo sapiens (human),IC50,>100000
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,GABA A receptor alpha-1/beta-1/gamma-2,Homo sapiens (Human),Kd, 1
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,GABA,na,Ki, 4.5
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,GABA A receptor alpha-6/beta-2/gamma-2,HUMAN,Ki,>10000
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,GABA receptor alpha-2/beta-3/gamma-2 subunit,Homo sapiens,Ki, 0.59
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,GABA A receptor alpha-2/beta-2/gamma-2,Homo sapiens (Human),EC50, 12
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,Bromodomain-containing protein 4,Homo sapiens (Human),Kd, 2460
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,Platelet activating factor receptor,HUMAN,Ki, 699
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,Platelet activating factor receptor,Cavia porcellus,IC50, 22000
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 21
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A)),Homo sapiens (Human),Kd, 4
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,GABA A receptor alpha-3/beta-2/gamma-2,HUMAN,Ki, 3
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,Cholecystokinin receptor,RAT,IC50, 64000
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,GABA receptor alpha-5/beta-3/gamma-2 subunit,Homo sapiens (Human),Ki, 1.5
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,GABA A receptor alpha-1/beta-1/gamma-2,Homo sapiens (Human),EC50, 37
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,Platelet activating factor receptor,Cavia porcellus,IC50, 11100
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,GABA receptor alpha-3/beta-3/gamma-2 subunit,HUMAN,Ki, 1.4
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,Cholecystokinin receptor,RAT,IC50, 39000
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A)),Homo sapiens (Human),EC50, 10
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.945
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,Opioid receptor,Rattus norvegicus (rat),Ki, 405
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,P-glycoprotein 1,Homo sapiens (Human),IC50, 7500
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,Voltage-gated potassium channel,Homo sapiens (human),IC50, 9772.37
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,Cytochrome P450 2B6,Homo sapiens (Human),Ki, 10000
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,Kappa-type opioid receptor,Homo sapiens (human),Ki, 15.8
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,Delta-type opioid receptor,Homo sapiens (human),Ki, 132.2
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 14.1
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,Mas-related G protein-coupled receptor X2 (MRGPRX2),Homo sapiens (Human),EC50, 4.4e+4
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,Norepinephrine transporter,RAT,Ki, 702
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 728
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,DRD2,BOVINE,Ki, 2700
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,OPRD1,GUINEA PIG,Ki, 37.3
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,Aldehyde oxidase,Rattus norvegicus,Ki, 30
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,DRD1,BOVINE,Ki,>10000
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 371
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.6
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,mu/kappa opioid receptor,GUINEA PIG,Ki, 1.4
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,mu/kappa opioid receptor,GUINEA PIG,Ki, 1
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Delta-type opioid receptor,Homo sapiens (human),IC50, 450
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 77
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Delta-type opioid receptor,Homo sapiens (human),IC50, 8400
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Voltage-gated potassium channel,Homo sapiens (human),IC50, 1819.7
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Delta-type opioid receptor,Homo sapiens (human),IC50, 13000
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Delta-type opioid receptor,Homo sapiens (human),Ki, 152.7
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.02
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Delta-type opioid receptor,Homo sapiens (human),Ki, 77
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Histamine H1 receptor,RAT,IC50, 19952.62
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki,>1
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,P-glycoprotein 1,Homo sapiens (Human),IC50, 6500
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Opioid receptors; mu & delta,Rattus norvegicus (rat),EC50, 8
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,"Nociceptin/Orphanin FQ, NOP receptor",MOUSE,Ki, 39.6
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),IC50, 1030
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 400
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 57
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,OPRD1,GUINEA PIG,Ki, 73.8
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Histamine H1 receptor,Homo sapiens (human),IC50, 147910.84
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),EC50, 300
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.39
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Kappa-type opioid receptor,Homo sapiens (human),Ki, 84.8
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Delta-type opioid receptor,MOUSE,Ki, 568
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 31
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Pregnane X receptor (PXR),Homo sapiens (Human),EC50, 31600
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),IC50, 2080
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 151.2
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.020000
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1.3
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),IC50, 451
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Kappa-type opioid receptor,Homo sapiens (human),Ki, 57
Fentanyl,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,Mu-type opioid receptor,MOUSE,Ki, 0.45
Valproic Acid,CCCC(CCC)C(O)=O,Carbonic anhydrase 2,Homo sapiens (human),Ki, 113000
Valproic Acid,CCCC(CCC)C(O)=O,Histone deacetylase,Homo sapiens (Human),IC50,>2000000
Valproic Acid,CCCC(CCC)C(O)=O,Carbonic anhydrase,Homo sapiens (human),Ki, 101000
Valproic Acid,CCCC(CCC)C(O)=O,Carbonic anhydrase 2,Homo sapiens (human),Ki, 110000
Valproic Acid,CCCC(CCC)C(O)=O,Carbonic anhydrase 2,Homo sapiens (human),Ki, 93000
Valproic Acid,CCCC(CCC)C(O)=O,Histone deacetylase 3/NCoR1,Homo sapiens (human),IC50, 161000
Valproic Acid,CCCC(CCC)C(O)=O,Histone deacetylase 8,Homo sapiens (human),IC50, 103000
Valproic Acid,CCCC(CCC)C(O)=O,Uridine-5&#39;-diphosphoglucuronosyltransferase 2B7,Homo sapiens (Human),Ki, 1600000
Valproic Acid,CCCC(CCC)C(O)=O,Histone deacetylase 1/3/5/8,Homo sapiens (Human),IC50,>2000000
Valproic Acid,CCCC(CCC)C(O)=O,Carboxylesterase 2,Homo sapiens,Ki, 7900000
Valproic Acid,CCCC(CCC)C(O)=O,Histone deacetylase 4,Homo sapiens (Human),IC50,>2000000
Valproic Acid,CCCC(CCC)C(O)=O,Histone deacetylase 7 (HDAC7),Homo sapiens (human),IC50,>2000000
Valproic Acid,CCCC(CCC)C(O)=O,Histone deacetylase 1,Homo sapiens (human),IC50, 39000
Valproic Acid,CCCC(CCC)C(O)=O,Cytochrome P450 2A6,Homo sapiens (Human),Ki, 9150000
Valproic Acid,CCCC(CCC)C(O)=O,Aldehyde reductase,Sus scrofa,IC50, 89000
Valproic Acid,CCCC(CCC)C(O)=O,Solute carrier family 22 member 6,Mus musculus,Ki, 56234.13
Valproic Acid,CCCC(CCC)C(O)=O,Solute carrier family 22 member 6,Mus musculus,Ki, 56234
Valproic Acid,CCCC(CCC)C(O)=O,Bile salt export pump (BSEP),Homo sapiens (Human),IC50,>1000000
Valproic Acid,CCCC(CCC)C(O)=O,Carbonic anhydrase 2,Homo sapiens (human),Ki, 83000
Valproic Acid,CCCC(CCC)C(O)=O,Solute carrier family 22 member 6,Mus musculus,Ki, 56234.13
Valproic Acid,CCCC(CCC)C(O)=O,Aldose reductase (ALR2),Bos taurus (Cattle),IC50, 57400
Valproic Acid,CCCC(CCC)C(O)=O,NAD-dependent protein deacetylase sirtuin-5 (SIRT5),Homo sapiens (Human),IC50,>100000
Valproic Acid,CCCC(CCC)C(O)=O,Carbonic anhydrase,Homo sapiens (human),Ki, 310000
Valproic Acid,CCCC(CCC)C(O)=O,Aldehyde reductase,Rattus norvegicus,IC50, 50100
Valproic Acid,CCCC(CCC)C(O)=O,Bile salt export pump,Rattus norvegicus,IC50,>1000000
Valproic Acid,CCCC(CCC)C(O)=O,Aldehyde reductase,Homo sapiens (human),IC50, 50100
Valproic Acid,CCCC(CCC)C(O)=O,Carbonic anhydrase,Homo sapiens (human),Ki, 92000
Valproic Acid,CCCC(CCC)C(O)=O,Carbonic anhydrase,Homo sapiens (human),Ki, 450000
Valproic Acid,CCCC(CCC)C(O)=O,Acyl-CoA: cholesterol acyltransferase (ACAT),Homo sapiens (Human),Ki, 363000
Valproic Acid,CCCC(CCC)C(O)=O,Histone deacetylase HD2,Zea mays,IC50, 128000
Valproic Acid,CCCC(CCC)C(O)=O,Solute carrier family 22 member 20,Mus musculus,Ki, 6600
Valproic Acid,CCCC(CCC)C(O)=O,Aldose reductase,Rattus norvegicus,IC50, 56100
Valproic Acid,CCCC(CCC)C(O)=O,Solute carrier family 22 member 20,Mus musculus,Ki, 6606.93
Valproic Acid,CCCC(CCC)C(O)=O,Coagulation factor VII/tissue factor,Homo sapiens,IC50, 1500000
Valproic Acid,CCCC(CCC)C(O)=O,Aldehyde reductase (ALR1),Bos taurus (Cattle),IC50, 5.74e+4
Valproic Acid,CCCC(CCC)C(O)=O,Histone deacetylase,Homo sapiens (human),IC50, 62000
Valproic Acid,CCCC(CCC)C(O)=O,Solute carrier family 22 member 20,Mus musculus,Ki, 6606.93
Valproic Acid,CCCC(CCC)C(O)=O,Aldose reductase-related protein 1,Rattus norvegicus,IC50, 56100
Valproic Acid,CCCC(CCC)C(O)=O,Aldose reductase,Rattus norvegicus,IC50, 380000
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 1698.24
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki,>10000
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,DRD2,BOVINE,Kd, 1.6
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki,>10000
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 21
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,DRD2,BOVINE,IC50,>1000
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki,>10000
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki,>10000
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Adrenergic receptor alpha,Rattus norvegicus (rat),Ki, 5495.41
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 630.96
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki, 1659.59
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 8.1
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 954.99
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 0.87
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Dopamine receptor,Rattus norvegicus (Rat),Ki, 0.45
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Adrenergic alpha1B,Homo sapiens (Human),Ki,>10000
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 57
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 691.83
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 3.1
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Dopamine D1 and D2 receptor,Homo sapiens (Human),EC50,>10000
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 10.47
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,DOPAMINE,RAT,Ki,>100000
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 128.82
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki,>10000
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 1.9
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),IC50, 280
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki,>10000
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki,>10000
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Dopamine D5 receptor,Homo sapiens (Human),Ki,>10000
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,CFTR,Homo sapiens,EC50,>50000
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,DRD1,BOVINE,Ki,>20000
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki, 8317.64
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki,>10000
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Beta-1 adrenergic receptor,Homo sapiens (human),Ki,>10000
Pramipexole,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Alpha adrenergic receptor (1a and 1d),HUMAN,Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Astrosclerin-3,Astrosclera willeyana,Ki, 378
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine D1 receptor,Mus musculus (Mouse),Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Beta-carbonic anhydrase,Helicobacter pylori (strain G27),Ki, 179
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,"Carbonic anhydrase, alpha family",Thiomicrospira crunogena (strain XCL-2),Ki, 873
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic Anhydrase VB,Homo sapiens (human),Ki, 18
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,adrenergic Alpha2,RAT,Ki, 682
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine D2 receptor,Mus musculus (Mouse),Ki, 34
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonate dehydratase,Sulfurihydrogenibium sp. (strain YO3AOP1),Ki, 67
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 20
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,DRD1,BOVINE,Ki, 50000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 180
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic anhydrase 2,Homo sapiens (human),Ki, 40
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic anhydrase,Homo sapiens (human),Ki, 1200
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 200
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 1200
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Muscarinic receptor M2 and M3,RAT,Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Cytochrome P450 2J2,Homo sapiens (Human),IC50,>50000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic Anhydrase (mtCA 1),Mycobacterium tuberculosis,Ki, 2300
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine receptor,RAT,Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic anhydrase,Anopheles gambiae,Ki, 30
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,DOPAMINE,RAT,Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine D2 receptor,Mus musculus (Mouse),Ki, 1063
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,DOPAMINE,RAT,Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Histamine H1 receptor,RAT,Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine receptor,RAT,Ki, 52
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic anhydrase 6 (CA-VI),Homo sapiens (Human),Ki, 0.8
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Kd, 1.5
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Alpha carbonic anhydrase,Stylophora pistillata,Ki, 430
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic Anhydrase III,Homo sapiens (human),Ki, 10600
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 4.2
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 5
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic anhydrase 9,Homo sapiens (human),Ki, 31
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Bile salt export pump (BSEP),Homo sapiens (Human),IC50,>1000000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,DRD2,RABBIT,Ki, 300
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 4.8
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,beta-Carbonic Anhydrase,Candida albicans (Yeast),Ki, 760
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 81
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,&#946;-Carbonic anhydrase 2 (CA 2),Mycobacterium tuberculosis,Ki, 266
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 92
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic anhydrase,Saccharomyces cerevisiae,Ki, 124
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,DRD1,BOVINE,Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 230
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 3000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic Anhydrase VA,Homo sapiens (human),Ki, 174
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 4634
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,HTR3A,Mus musculus (house mouse),Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic anhydrase 12,Homo sapiens (human),Ki, 3.9
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic Anhydrase XV,Mus musculus (mouse),Ki, 73
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine receptor,Rattus norvegicus (Rat),Ki, 0.71
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic Anhydrase IV,Bos taurus (bovine),IC50, 620
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Delta carbonic anhydrase,Thalassiosira weissflogii,Ki, 259
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic anhydrase 2,Homo sapiens (human),Ki, 40
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic anhydrase,Homo sapiens (human),Ki, 1200
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,DOPAMINE,RAT,Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki,>1000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 51
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Sigma,HUMAN,IC50,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic Anhydrase (mtCA 3),Mycobacterium tuberculosis,Ki, 7920
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine D1 receptor,Mus musculus (Mouse),Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Bile salt export pump,Rattus norvegicus,IC50,>1000000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic anhydrase 6 (CA-VI),Homo sapiens (Human),Ki, 0.8
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine D5 receptor,Homo sapiens (Human),Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine D1 receptor,Mus musculus (Mouse),Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic Anhydrase 2 (Can2),Cryptococcus neoformans var. grubii (Filobasidiella neoformans var. grubii),Ki, 812
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 7.9
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic anhydrase 9,Homo sapiens (human),Ki, 31
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic anhydrase,Stylophora pistillata,Ki, 415
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 16
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 59
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,DRD1,CANINE,IC50, 200
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 6.4
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,HTR6,RAT,Ki, 5000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 1400
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 4500
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 329
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Dopamine D2 receptor,Mus musculus (Mouse),Ki, 14.45
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,ADRB2,Rattus norvegicus,Ki,>10000
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic Anhydrase (hpCA),Helicobacter pylori J99,Ki, 204
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,DRD2,RABBIT,Ki, 20
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 0.55
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 53
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 1300
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 0.08
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 2.6
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 6.62
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Adrenergic receptor alpha-1,Homo sapiens (Human),Ki, 12
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 300
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 1000
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 48
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 1.2
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,"Cholinergic, muscarinic",RABBIT,Ki, 1000
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,adrenergic Alpha2,RAT,Ki, 390
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,CCKBR,RAT,Ki, 1000
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki, 2.4
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Histamine H1 receptor,RAT,Ki, 510
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Serotonin 1B/1D receptor,Rattus norvegicus (Rat),Ki, 130
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 0.25
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 1600
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 1.9
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Cysteinyl leukotriene receptor 1,GUINEA PIG,Ki, 1000
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Histamine H1 receptor,Homo sapiens (human),Ki, 4.6
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Transporter,Rattus norvegicus (rat),Ki, 48
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 3.8
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Prostanoid TP receptor,Homo sapiens (Human),Ki, 1000
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Adrenergic receptor alpha-2,Homo sapiens (Human),Ki, 390
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 3
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 1.1
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,HTR2C,PIG,Ki, 13
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 110
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 0.8
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1000
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 59
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 9.5
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,NT,GUINEA PIG,Ki, 1000
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1000
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 61
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 5.3
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Cholecystokinin B,GUINEA PIG,Ki, 1000
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 0.5
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Calcium channel,RAT,Ki, 5000
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki, 0.99
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Substance P,HUMAN,Ki, 1000
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,HTR3A,Mus musculus (house mouse),Ki, 2830
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 2440
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Serotonin (5-HT) receptor,Homo sapiens,Ki, 360
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,DOPAMINE,RAT,Ki, 9.5
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Beta-1 adrenergic receptor,Homo sapiens (human),Ki, 2570
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Norepinephrine transporter,RAT,Ki, 1000
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 1000
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 154
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Histone H1,Homo sapiens (Human),Ki, 15
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Dopamine receptor,Rattus norvegicus (Rat),Ki, 7.5
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Delta-type opioid receptor,MOUSE,Ki, 1000
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,CHRM5,Homo sapiens,Ki, 1600
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,5-hydroxytryptamine receptor 7 (5HT7),Mus musculus (Mouse),Ki, 4.9
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 2.8
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Voltage-gated sodium channel subunit alpha Nav1.8,Rattus norvegicus (Rat),Ki, 2620
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 0.55
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Muscarinic receptor M2 and M3,RAT,Ki, 5000
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Voltage-gated potassium channel,Homo sapiens (human),Ki, 169
Ziprasidone,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki, 5000
Clonidine,ClC1=CC=CC(Cl)=C1NC1=NCCN1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 7.94
Clonidine,ClC1=CC=CC(Cl)=C1NC1=NCCN1,adrenergic Alpha2,PIG,Ki, 288.4
Clonidine,ClC1=CC=CC(Cl)=C1NC1=NCCN1,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 4.5
Clonidine,ClC1=CC=CC(Cl)=C1NC1=NCCN1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki,>10000
Clonidine,ClC1=CC=CC(Cl)=C1NC1=NCCN1,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 21.38
Clonidine,ClC1=CC=CC(Cl)=C1NC1=NCCN1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 21
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Histamine H2 Receptor,Homo sapiens (human),Ki,>10000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 0.6
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 3510
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Beta-1 adrenergic receptor,Homo sapiens (human),Ki, 141
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 3220
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,"Protein kinase C, gamma",Homo sapiens (human),Ki, 8000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Histone H1,Homo sapiens (Human),Ki, 28
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 74
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 21
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 3.6
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,GABA,na,Ki,>10000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Multidrug and toxin extrusion protein 2,Homo sapiens,IC50,>500000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Benzodiazepine central,RAT,Ki,>10000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Voltage-gated potassium channel,Homo sapiens (human),Ki, 598
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 22
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Prostaglandin E2 receptor,Homo sapiens (Human),Ki,>10000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki, 163
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 0.6
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Delta-type opioid receptor,Homo sapiens (human),Ki,>10000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,DOPAMINE,RAT,Ki, 0.8
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Dopamine D1B,RAT,Ki, 1200
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 4677
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki,>10000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 98
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,PKC alpha and beta-2,Homo sapiens (human),Ki,>10000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 0.8
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 3.7
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Serotonin (5-HT) receptor,Rattus norvegicus (Rat),Ki, 76
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Glutamate-NMDA,RAT,Ki, 4001
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Dopamine receptor,Rattus norvegicus (Rat),Ki, 6.06
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 26
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Serotonin (5-HT) receptor,Homo sapiens,Ki, 8000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,P-glycoprotein 1,Homo sapiens (Human),IC50, 780
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Solute carrier family 22 member 2,Homo sapiens,IC50, 239000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 16
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 1520
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 9.6
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 6780
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 0.4
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Dopamine receptor,RAT,Ki, 260
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 0.6
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 200
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 102
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki, 68
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,HTR6,RAT,Ki, 161
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,CHRM5,Homo sapiens,Ki, 2330
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,HRH3,GUINEA PIG,Ki, 224
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 1080
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Dopamine D5 receptor,Homo sapiens (Human),Ki, 615
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Serotonin (5-HT) receptor,RAT,Ki, 630
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 0.200000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 76
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 2090
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Histamine H1 receptor,Homo sapiens (human),Ki, 25
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 825
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 5.6
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Adrenergic alpha1B,Homo sapiens (Human),Ki, 34.8
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Serotonin (5-HT) receptor,Homo sapiens (Human),Ki, 1240
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Kappa-type opioid receptor,Homo sapiens (human),Ki,>10000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Mu-type opioid receptor,Homo sapiens (human),Ki,>10000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Multidrug and toxin extrusion protein 1,Homo sapiens,IC50, 130000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Histamine receptor (H4),Homo sapiens (human),Ki,>10000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 1.000000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Histamine H1 receptor,RAT,IC50,>3000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 57
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 0.360000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 0.4
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Dopamine D5 receptor,Homo sapiens (Human),Ki, 1051
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 37
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 90
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,"1,3-beta-glucan synthase component GLS2",Saccharomyces cerevisiae,IC50, 3860
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 310
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 0.6
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Prostaglandin E2 receptor EP4 subtype (EP4),Homo sapiens (Human),Ki,>10000
Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki, 830
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Cholecystokinin receptor,Homo sapiens (human),IC50,>100000
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,GABA A Alpha2Beta1Gamma2,Homo sapiens (Human),Ki, 1.2
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Platelet activating factor receptor,HUMAN,Ki, 2610
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki,>10000
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,CHRM5,Homo sapiens,Ki,>10000
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,GABA receptor alpha-6/beta-3/gamma-2 subunit,HUMAN,Ki,>10000
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki,>10000
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki,>10000
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,GABA A receptor alpha-3/beta-2/gamma-2,HUMAN,EC50, 69
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,GABA receptor alpha-1/beta-3/gamma-2 subunit,Homo sapiens (Human),Ki, 0.80
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 0.31
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Cholecystokinin receptor,Homo sapiens (human),IC50,>100000
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Histamine H1 receptor,Homo sapiens (human),Ki,>10000
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki,>10000
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,GABA A receptor alpha-1/beta-1/gamma-2,Homo sapiens (Human),Kd, 1
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,GABA,na,Ki, 4.5
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki,>10000
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,GABA A receptor alpha-6/beta-2/gamma-2,HUMAN,Ki,>10000
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,GABA receptor alpha-2/beta-3/gamma-2 subunit,Homo sapiens,Ki, 0.59
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,GABA A receptor alpha-2/beta-2/gamma-2,Homo sapiens (Human),EC50, 12
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Bromodomain-containing protein 4,Homo sapiens (Human),Kd, 2460
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Platelet activating factor receptor,HUMAN,Ki, 699
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Platelet activating factor receptor,Cavia porcellus,IC50, 22000
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki,>10000
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 21
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki,>10000
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A)),Homo sapiens (Human),Kd, 4
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,GABA A receptor alpha-3/beta-2/gamma-2,HUMAN,Ki, 3
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Cholecystokinin receptor,RAT,IC50, 64000
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,GABA receptor alpha-5/beta-3/gamma-2 subunit,Homo sapiens (Human),Ki, 1.5
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,GABA A receptor alpha-1/beta-1/gamma-2,Homo sapiens (Human),EC50, 37
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Platelet activating factor receptor,Cavia porcellus,IC50, 11100
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki,>10000
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,GABA receptor alpha-3/beta-3/gamma-2 subunit,HUMAN,Ki, 1.4
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Cholecystokinin receptor,RAT,IC50, 39000
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A)),Homo sapiens (Human),EC50, 10
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Voltage-gated potassium channel,Homo sapiens (human),IC50, 251189
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),IC50, 30
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Dopamine receptor,Rattus norvegicus (Rat),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Calcium channel,RAT,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Histamine H2 receptor,Cavia porcellus (domestic guinea pig),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 1540
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Glutamate kainate,RAT,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 30
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),IC50, 149
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50, 126
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50, 300
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Potassium Channel (Ca2+ dependent),RAT,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 2230
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Adenosine transporter,HUMAN,Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Protein kinase C,MOUSE,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Monoamine Oxidase Type B (MAO-B),Rattus norvegicus (rat),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Adenosine transporter,RAT,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Norepinephrine transporter,RAT,Ki, 938
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Serum albumin,Rattus norvegicus,Kd, 5.1
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Neuropeptide Y receptor type 1,HUMAN,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 7.7
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 640
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 1900
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,HRH1,BOVINE,Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Kd, 8.9
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Glutamate-NMDA,RAT,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50, 300
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),IC50, 61
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,ADENOSINE A2,BOVINE,Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent dopamine transporter,Homo sapiens (human),Kd, 9300
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,TACR2,mouse,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Cholecystokinin receptor,MOUSE,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Cannabinoid receptor 2,Homo sapiens (human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,ADRB2,Rattus norvegicus,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50, 60
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium (Site 2),Rattus norvegicus,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Transporter,Rattus norvegicus (rat),IC50, 640
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Norepinephrine Monoamine transporters,Rattus norvegicus,Ki, 220
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,GABA A,BOVINE,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Adenosine receptors; A1 & A2a,Homo sapiens (human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 530
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,"Glycine, non-strychnine",RAT,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,HTR3A,Mus musculus (house mouse),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Norepinephrine Monoamine transporters,Rattus norvegicus,Ki, 138
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 0.1
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent dopamine transporter,Homo sapiens (human),Kd, 3500
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,HTR4,GUINEA PIG,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,adrenergic Alpha2,RAT,Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Adenylate cyclase Forskolin,RAT,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Voltage-gated sodium channel subunit Nav1.5,Homo sapiens (Human),IC50, 199526
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Serotonin (5-HT) receptor,Homo sapiens,Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 240
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Kd, 1060
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 20
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 400
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 531.3
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,SLC6A3,GUINEA PIG,Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Neurokinin 3 receptor,mouse,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium (Site 1),Rattus norvegicus,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,DOPAMINE,RAT,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Nicotinic Alpha-Bungarotoxin,Bungarus multicinctus,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Monoamine oxidase,Rattus norvegicus (rat),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 2792
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Muscarinic receptor M2 and M3,RAT,Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 2070
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,GRIA3,RAT,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Norepinephrine transporter,RAT,Ki, 0.64
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent dopamine transporter,Homo sapiens (human),IC50, 4430
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50, 205
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,ADRA2B,MOUSE,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,"Nitric-oxide synthase, brain",Rattus norvegicus (rat),Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50, 300
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 1600
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Histamine H1 receptor,RAT,Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Neurokinin 1 receptor,Rattus norvegicus (rat),Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 2004
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Ecto-5&#39;-nucleotidase (e5&#39;NT),Rattus norvegicus (Rat),Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Adrenergic receptor beta,Rattus norvegicus (Rat),Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Kd, 30
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 1160
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Alpha adrenergic receptor 1A and 1B,Rattus norvegicus (rat),Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 4700
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,ADENOSINE A2,BOVINE,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Cannabinoid receptor 1,Homo sapiens (human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Adenosine receptor A1,Rattus norvegicus (rat),Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Renal Outer Medullary Potassium (ROMK),Rattus norvegicus (Rat),Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,HRH3,RAT,Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent dopamine transporter,Homo sapiens (human),IC50, 19600
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),IC50, 7
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,CHRM5,Homo sapiens,Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Calcium channel (Type N),na,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Voltage-gated potassium channel subunit Kv4.3,Homo sapiens,IC50, 5011872
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 2.8
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,CHRM5,Homo sapiens,Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Inositol Triphosphate,RAT,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 5800
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Kd, 1800
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,SOMATOSTATIN,RAT,Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Histamine H1 receptor,Homo sapiens (human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Histamine H2 receptor,Cavia porcellus (domestic guinea pig),Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 1000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Serotonin (5-HT) receptor,HUMAN,Ki,>10000
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 2580
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,Homo sapiens (human),Ki, 0.67
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenergic Alpha,HUMAN,IC50, 16900
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Neurotrophic tyrosine kinase receptor,Homo Sapiens,Kd, 1800000
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Calcium channel,RAT,IC50, 3750
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 0.17
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 37
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET,Homo sapiens (Human),IC50, 1500
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 2000
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine receptor (H4),Homo sapiens (human),Ki, 33.6
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,CHRM5,Homo sapiens,Ki, 97
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 21
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Serum albumin,Rattus norvegicus,Kd, 1.3
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 1140
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium channel protein type 7 subunit alpha,Homo sapiens,IC50, 20000
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 206
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Cytochrome P450 2D6 (2D6),Homo sapiens (Human),IC50, 2300
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,GABA transporter,Mus musculus,IC50, 169824
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 55
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium channel alpha subunit,Homo sapiens (Human),IC50, 1000
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50, 0.04
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Cytochrome P450 2D3,Rattus norvegicus,IC50, 14200
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine D5 receptor,Homo sapiens (Human),Ki, 170
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine transporter,RAT,Ki, 8.6
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,DOPAMINE,RAT,Ki, 81
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 41
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Cytochrome P450 2D18,Rattus norvegicus,IC50, 19300
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 84
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 65
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 50
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,Homo sapiens (human),Ki, 6.3
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 89
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET,Homo sapiens (Human),IC50, 10000
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Cytochrome P450 2D2,Rattus norvegicus,IC50, 1900
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 850
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,HTR6,MOUSE,Ki, 89.13
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 2500
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic receptor M2 and M3,RAT,Ki, 2.6
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 9.6
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,HTR6,RAT,Ki, 63.10
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 2030
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 2580
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-gated sodium channel subunit alpha Nav1.2 (Nav1.2),Homo sapiens (Human),IC50, 3100
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 16
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 114
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 8.5
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 214
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 4.3
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 18
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-gated potassium channel,Homo sapiens (human),IC50, 3280
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine receptor (H3),Homo sapiens (human),Ki,>1000
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-gated sodium channel subunit Nav1.5,Homo sapiens (Human),IC50, 1600
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,CHRM5,Homo sapiens,Ki, 15.7
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Cytochrome P450 2D1,Rattus norvegicus,IC50, 204000
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,adrenergic Alpha2,RAT,Ki, 340
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 5300
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,HTR6,RAT,Ki, 148
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,RAT,Ki, 4.1
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 12.8
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H2 receptor,Cavia porcellus (domestic guinea pig),IC50, 660
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 15
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 2.8
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki,>10000
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H2 receptor,Cavia porcellus (domestic guinea pig),IC50, 7000
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Cytochrome P450 2C8,Homo sapiens (Human),Ki, 49900
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 11
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 5
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 40
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 4.4
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 4.3
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-gated L-type calcium channel,Homo sapiens,IC50, 11600
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,ADRB2,Rattus norvegicus,Ki,>10000
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,RAT,Ki, 46
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 1.49
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET,Homo sapiens (Human),IC50, 1000
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,GABA transporter 1,Rattus norvegicus,IC50, 389000
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 196
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine transporter,RAT,Ki, 0.99
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 2570
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 300
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 60
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 13.3
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 450
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 7.2
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki,>10000
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 294
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 219
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 77.6
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Trypanothione Reductase (TryR),Trypanosoma brucei brucei,IC50, 3400
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Trypanothione reductase,Trypanosoma cruzi,Ki, 6500
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 56
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 35.5
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Proteasome subunit alpha type-6,Homo sapiens,EC50, 12400
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki,>10000
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 0.05
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,HTR3A,Mus musculus (house mouse),Ki, 85.1
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 1230
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 2190
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Calcium channel,RAT,IC50, 11600
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki,>10000
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 22
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,SLC6A4,MOUSE,IC50, 70
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 9.42
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 700
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki,>10000
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 38
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 30
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 112
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,HTR6,RAT,Ki, 53.8
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,TPA: Essential protein of the mitochondrial intermembrane space,Saccharomyces cerevisiae S288c,IC50, 37800
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 64.6
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Histamine H2 receptor,Cavia porcellus (domestic guinea pig),IC50, 720
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 3.2
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Norepinephrine transporter,MOUSE,IC50, 900
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 15.5
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,adrenergic Alpha2,RAT,Ki,>10000
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 0.14
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Adrenergic Alpha,HUMAN,IC50, 19300
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Norepinephrine transporter,RAT,Ki, 14.6
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 525
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,Histamine H1 receptor,RAT,IC50, 0.20
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine D2 receptor,Mus musculus (Mouse),Ki, 726
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki,>10000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,Ki, 0.65
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 160
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium channel protein type 7 subunit alpha,Homo sapiens,IC50, 3600
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 110
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 210
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,DRD1,BOVINE,Ki,>10000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenergic receptor beta,Rattus norvegicus (Rat),Ki,>10000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 0.13
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 2450
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic receptor M2 and M3,RAT,Ki, 320
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Calcium channel,RAT,IC50, 11700
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,Ki, 12
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 942
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,Homo sapiens (human),Ki, 1.4
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,HTR6,RAT,Ki, 190
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 8500
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 20
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 3100
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,SLC6A4,MOUSE,Ki, 5
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine transporter,MOUSE,Ki, 8114
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,CHRM5,Homo sapiens,Ki, 143
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 112
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 244
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,Homo sapiens (human),Ki, 60
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,CHRM5,RAT,IC50, 300
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Cytochrome P450 2J2,Homo sapiens (Human),IC50,>50000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 8.7
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 106
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 94
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,HTR3A,Mus musculus (house mouse),Ki, 4402
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Multidrug and toxin extrusion protein 2,Homo sapiens,IC50,>100000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenergic Alpha,HUMAN,IC50, 56800
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 150
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-gated potassium channel,Homo sapiens (human),IC50, 3388
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 1379
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 520
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki,>10000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenaline alpha2,RAT,IC50, 9900
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H3 receptor,Rattus norvegicus (rat),Ki,>5000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 5465
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 0.15
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 1561
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 60
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,DRD2,BOVINE,Ki, 180
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenaline alpha1,RAT,IC50, 16000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Serum albumin,Homo sapiens,Kd, 851138
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-gated potassium channel,Homo sapiens (human),IC50, 1380.38
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki,>10000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,adrenergic Alpha2,RAT,Ki, 4600
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,RAT,Ki, 2
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 94
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 32
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-dependent L-type calcium channel subunit alpha-1C,Cavia porcellus,IC50, 1709
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 160
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 1000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 42
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,adrenergic Alpha2,RAT,Ki, 9200
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenergic Alpha,HUMAN,IC50, 17100
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 6400
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Solute carrier family 22 member 2,Homo sapiens,IC50, 600
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenergic Alpha,HUMAN,IC50, 27700
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 17.6
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,CHRM5,Homo sapiens,Ki, 83
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 300
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 102
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 620
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 16
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 0.49
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine transporter,RAT,Ki, 0.06
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenaline alpha1,RAT,Ki, 2800
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Pleiotropic ABC efflux transporter of multiple drugs,Saccharomyces cerevisiae S288c,IC50, 22000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H2 receptor,Cavia porcellus (domestic guinea pig),IC50, 1900
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 3780
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic receptor M2 and M3,RAT,Ki, 37
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Transporter,Rattus norvegicus (rat),Ki, 0.78
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 129
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,Homo sapiens (human),Ki, 16
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,HTR3A,Mus musculus (house mouse),Ki, 3651
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine transporter,BOVINE,Ki, 8.88
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,SLC6A3,MOUSE,Ki, 42
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 5800
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-gated L-type calcium channel,Homo sapiens,IC50, 8300
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Prion protein,Homo sapiens,EC50, 10000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,RAT,Ki, 124
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H2 receptor,Cavia porcellus (domestic guinea pig),IC50, 3800
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 4000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,SLC6A4,MOUSE,IC50, 9300
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Multidrug and toxin extrusion protein 1,Homo sapiens,IC50, 10000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-hydroxytryptamine receptor 2C (5HT2C),Mus musculus (Mouse),Ki, 160
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Calcium channel,RAT,IC50, 4050
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenaline alpha2,RAT,IC50, 10000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-gated sodium channel subunit Nav1.5,Homo sapiens (Human),IC50, 1520
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 387
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Kd, 0.83
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 66
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 149
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adenosine receptor A3,Homo sapiens (human),IC50, 4.4
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 51
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine receptor (H3),Homo sapiens (human),Ki,>5000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 31
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,ADRB2,Rattus norvegicus,Ki,>10000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Cytochrome P450 2J2,Homo sapiens (Human),IC50,>50000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,DOPAMINE,RAT,Ki, 3000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 397.0
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 190
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine transporter,RAT,Ki, 11
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine transporter,BOVINE,Ki, 93.6
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki,>10000
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 350
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine transporter,MOUSE,Ki, 12
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 23
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 0.84
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine receptor,Rattus norvegicus (Rat),Ki, 0.9
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Cruzipain,Trypanosoma cruzi,IC50, 189000
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 1.2
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 52
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 0.72
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,DRD1,BOVINE,Ki, 113
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,HTR2C,PIG,Ki, 15.85
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 41
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 79.43
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Twik-RElated Potassium (K+) channel 1 (TREK1),Homo sapiens (Human),IC50, 2700
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Prion protein,Homo sapiens,EC50, 2000
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Adrenergic Alpha,HUMAN,IC50, 49600
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,ADRA1A,PIG,Ki, 7.94
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Pleiotropic ABC efflux transporter of multiple drugs,Saccharomyces cerevisiae S288c,IC50, 4500
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine D5 receptor,Homo sapiens (Human),Ki, 133
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Cytochrome P450 2J2,Homo sapiens (Human),IC50, 24400
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 4
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 6.3
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 25.11
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 44
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine D2 receptor,Mus musculus (Mouse),Ki, 4.6
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Cytochrome P450 2D6 (2D6),Homo sapiens (Human),Ki, 7000
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Trypanothione reductase,Trypanosoma cruzi,Ki, 3200
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine receptor,Rattus norvegicus (Rat),Ki, 35
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 10
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Pleiotropic ABC efflux transporter of multiple drugs,Saccharomyces cerevisiae S288c,IC50, 700
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Trypanothione reductase,Trypanosoma cruzi,Ki, 570
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Serum albumin,Homo sapiens,Kd, 54954
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Pleiotropic ABC efflux transporter of multiple drugs,Saccharomyces cerevisiae S288c,IC50, 3200
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,HTR6,RAT,Ki, 5000
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine D1 receptor,Mus musculus (Mouse),Ki, 25
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Trypanothione reductase,Trypanosoma cruzi,Ki, 180
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Serum albumin,Rattus norvegicus,Kd, 1.2
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Trypanothione reductase,Trypanosoma cruzi,IC50, 765000
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 70
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,HTR2B,BOVINE,Ki, 6
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 540
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Aldehyde oxidase,Homo sapiens,Ki, 620
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Cytochrome P450 2C9,Homo sapiens (human),IC50,>50000
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,DOPAMINE,RAT,Ki, 25
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,DRD2,BOVINE,Ki, 10.2
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,adrenergic Alpha2,OPOSSUM,Ki, 26
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 1.8
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Trypanothione reductase,Trypanosoma cruzi,IC50, 139000
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,ADRA2C,OPOSSUM,Ki, 116
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Proteasome subunit alpha type-6,Homo sapiens,EC50, 9900
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Induced myeloid leukemia cell differentiation protein Mcl-1,Homo sapiens (human),IC50, 3773.276395
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 78
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 2
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,5-hydroxytryptamine receptor 7 (5HT7),Mus musculus (Mouse),Ki, 5011.87
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,HTR3A,Mus musculus (house mouse),Ki, 820
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 14.92
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 820
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Sodium channel protein type 7 subunit alpha,Homo sapiens,IC50, 4300
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Histamine receptor (H3),Homo sapiens (human),Ki,>1000
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 24
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Trypanothione reductase,Trypanosoma cruzi,Ki, 1100
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Cytochrome P450 3A,Homo sapiens (human),IC50, 23300
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Voltage-gated potassium channel,Homo sapiens (human),IC50, 1470
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Cytochrome P450 1A,Homo sapiens (human),IC50, 4140
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,ADRA2C,OK,Ki, 37
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,TPA: Essential protein of the mitochondrial intermembrane space,Saccharomyces cerevisiae S288c,IC50, 29100
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 1.4
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 1475
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine receptor,RAT,Ki, 9.7
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Trypanothione reductase,Trypanosoma cruzi,IC50, 307000
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 47
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Adrenergic Alpha,HUMAN,IC50, 4300
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 2150
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Trypanothione reductase,Trypanosoma cruzi,Ki, 1550
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Muscarinic receptor M2 and M3,RAT,Ki, 378
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 40
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,HTR6,RAT,Ki, 3.98
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 25
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,P-glycoprotein 1,Homo sapiens (Human),Ki, 600
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 1.8
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 5.4
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 0.28
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Cytochrome P450 2C19,Homo sapiens (human),IC50, 34100
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 5000
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 4.8
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,adrenergic Alpha2,RABBIT,Ki, 2686
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 11
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,HTR7,GUINEA PIG,Ki,>10000
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Adrenergic receptor alpha,Rattus norvegicus (rat),Ki, 388
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Bile salt export pump (BSEP),Homo sapiens (Human),IC50, 30900
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,adrenergic Alpha2,BOVINE,Ki, 884
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 5.9
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,adrenergic Alpha2,PIG,Ki, 64
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,adrenergic Alpha2,RAT,Ki, 3050
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 1694.91
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Histamine H1 receptor,Homo sapiens (human),Ki, 19
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,NADPH oxidase 1,Homo sapiens,IC50,>17000
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 6.2
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Calmodulin,Homo sapiens,Ki, 19280
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 0.66
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Histamine H1 receptor,RAT,Ki, 26
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Adrenergic receptor alpha-2,NEONATAL RAT,Ki, 22
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,neutrophil cytosolic factor 1,Homo sapiens,IC50, 50000
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 0.2
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,5-HT1,Homo sapiens (human),Ki, 5882.35
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Calmodulin,Bos taurus,Kd, 1240
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,HTR6,RAT,Ki, 148
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 116.4
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Trypanothione reductase,Trypanosoma cruzi,IC50, 126000
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,ubiquitin-conjugating enzyme E2 N,Homo sapiens,IC50,>20000
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 4.7
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Histamine H1 receptor,Homo sapiens (human),Ki, 3
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Pleiotropic ABC efflux transporter of multiple drugs,Saccharomyces cerevisiae S288c,IC50, 1700
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,HTR6,MOUSE,Ki, 5011.87
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Bile salt export pump,Rattus norvegicus,IC50, 122300
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Histamine receptor (H4),Homo sapiens (human),Ki, 50.2
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Aldehyde oxidase,Oryctolagus cuniculus,IC50, 20000
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,DRD2,GUINEA PIG,Ki, 2.7
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 23
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,CHRM5,Homo sapiens,Ki, 42
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,ADRB2,Rattus norvegicus,Ki,>10000
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Trypanothione reductase,Trypanosoma cruzi,IC50, 1412000
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Adrenergic Alpha,HUMAN,IC50, 17200
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,GST-MALT lymphoma-associated translocation (MALT1),Homo sapiens (Human),IC50, 11800
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,GST-MALT lymphoma-associated translocation (MALT1),Homo sapiens (Human),IC50, 15800
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Histamine H1 receptor,RAT,Ki, 1.3
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Histamine H1 receptor,Homo sapiens (human),Ki, 2
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,GST-MALT lymphoma-associated translocation (MALT1),Homo sapiens (Human),IC50, 2670
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Trypanothione reductase,Trypanosoma cruzi,IC50, 1028000
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 900
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki,>10000
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 160
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Pleiotropic ABC efflux transporter of multiple drugs,Saccharomyces cerevisiae S288c,IC50, 7400
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Trypanothione reductase,Trypanosoma cruzi,IC50, 992000
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Histamine H1 receptor,RAT,Ki, 30
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,5-HT1,Homo sapiens (human),Ki,>10000
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,GST-MALT lymphoma-associated translocation (MALT1),Homo sapiens (Human),IC50, 8260
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Pleiotropic ABC efflux transporter of multiple drugs,Saccharomyces cerevisiae S288c,IC50, 11300
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,GST-MALT lymphoma-associated translocation (MALT1),Homo sapiens (Human),IC50, 5800
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,GST-MALT lymphoma-associated translocation (MALT1),Homo sapiens (Human),IC50, 15000
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Trypanothione reductase,Trypanosoma cruzi,Ki, 127000
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,GST-MALT lymphoma-associated translocation (MALT1),Homo sapiens (Human),IC50, 8690
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 149.25
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,GST-MALT lymphoma-associated translocation (MALT1),Homo sapiens (Human),IC50, 4000
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 159
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,DRD2,BOVINE,Ki, 71.5
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 15.87
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,GST-MALT lymphoma-associated translocation (MALT1),Homo sapiens (Human),IC50, 5700
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,DRD1,BOVINE,Ki, 7100
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Trypanothione reductase,Trypanosoma cruzi,Ki, 59100
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 5.88
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,Prion protein,Homo sapiens,EC50, 5000
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,NADPH oxidase 1,Homo sapiens,IC50,>17000
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Trace amine-associated receptor 1,Macaca mulatta,EC50, 5300
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki,>10000
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Monoamine oxidase,Bos taurus,Ki, 550000
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Sigma,HUMAN,Ki, 13.6
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Trace amine-associated receptor 1 (TAAR1),Mus musculus (Mouse),EC50, 70
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,OPIATE Sigma,RAT,Ki, 4.8
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Vesicular monoamine transporter 2 (VMAT2),Rattus norvegicus (Rat),Ki, 2460
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Monoamine oxidase,Bos taurus,Ki, 800000
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),EC50, 4698
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,trace amine-associated receptor 1,Homo sapiens,EC50, 1300
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 24.5
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Sigma,HUMAN,Ki, 1640
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Sigma,HUMAN,Ki, 31
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki,>10000
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 2137
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 650
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),EC50, 225
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,OPIATE Sigma,RAT,Ki, 46
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 114
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,HTR3A,Mus musculus (house mouse),Ki,>10000
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 736
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki,>10000
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Sigma,HUMAN,Ki, 8320
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Trace amine-associated receptor 1 (TAAR1),Rattus norvegicus (Rat),EC50, 1190
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki,>10000
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Trace amine-associated receptor 1 (TAAR1),Mus musculus (Mouse),EC50, 2440
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 1935
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 12.3
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,trace amine-associated receptor 1,Homo sapiens,EC50, 3300
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Norepinephrine transporter,RAT,Ki, 48
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki,>10000
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Trace amine-associated receptor 1,Macaca mulatta,EC50, 2500
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Monoamine Oxidase Type B (MAO-B),Rattus norvegicus (rat),Ki, 550000
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Trace amine-associated receptor 1 (TAAR1),Rattus norvegicus (Rat),EC50, 890
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Sigma,HUMAN,Ki, 660
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 600
Methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Monoamine Oxidase Type B (MAO-B),Rattus norvegicus (rat),Ki, 270000
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Cytochrome P450 2C9,Homo sapiens (human),IC50,>50000
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 500
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 400
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 2.29
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki,>10000
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Cytochrome P450 3A,Homo sapiens (human),IC50, 800
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),IC50, 3
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 84
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 240
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 120
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,HTR2C,PORCINE,Ki, 2298
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki,>10000
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 0.15
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki,>10000
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 19
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 3800
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Norepinephrine transporter,RAT,Ki, 380
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Norepinephrine transporter,RAT,Ki, 3411
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 520
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 390
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki,>10000
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Kd, 0.29
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 22
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 5600
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 3400
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 100
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 52
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,CHRM5,Homo sapiens,Ki, 3800
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Cytochrome P450 2C19,Homo sapiens (human),IC50, 310
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 33
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,15-Lipoxygenase (LoxA),Pseudomonas aeruginosa,IC50, 1.31e+4
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Histamine H1 receptor,Homo sapiens (human),Ki, 9000
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,ubiquitin-conjugating enzyme E2 N,Homo sapiens,IC50,>20000
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Norepinephrine transporter,RAT,Ki, 50
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 260
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 40
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 450
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 1000
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 460
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 1000
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent noradrenaline transporter,Homo sapiens (human),IC50, 3200
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 420
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 0.850
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,CHRM5,Homo sapiens,Ki, 1900
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 1380
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 30
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 630
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Transcriptional activator protein luxR,Vibrio fischeri,IC50, 27000
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Cytochrome P450 2C19,Homo sapiens (human),IC50, 22500
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,ADRB2,Rattus norvegicus,Ki,>10000
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Kd, 420
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 40
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,Ki, 159
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 9900
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 120
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 36
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 78.3
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 1430
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 10
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,adrenergic Alpha2,RAT,Ki, 1800
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 1300
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 427
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 1050
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 170
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Cytochrome P450 2D6 (2D6),Homo sapiens (Human),IC50, 2880
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 2800
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 250
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 230
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 400
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 5042
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 380
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 1400
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Muscarinic receptor M2 and M3,RAT,Ki, 232
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 129
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 70
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Norepinephrine transporter,RAT,Ki, 11
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 7800
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 1410
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Cytochrome P450 3A,Homo sapiens (human),IC50, 13600
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 0.9
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 130
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Cytochrome P450 2D6 (2D6),Homo sapiens (Human),IC50, 1400
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Transporter,Rattus norvegicus (rat),IC50, 22
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Cytochrome P450 1A,Homo sapiens (human),IC50, 29700
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 290
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,DOPAMINE,RAT,Ki, 6300
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Histamine H1 receptor,RAT,Ki,>10000
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 1160
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sigma,HUMAN,Ki, 57
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 3100
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 0.04
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 4800
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 477
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Histamine H1 receptor,Homo sapiens (human),Ki,>10000
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 26
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 70
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent dopamine transporter,Homo sapiens (human),IC50, 100
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 720
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 1250
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 3
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 3500
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki,>10000
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Cytochrome P450 2J2,Homo sapiens (Human),IC50, 18500
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Calcium channel,RAT,IC50, 2310
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 1200
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent dopamine transporter,Homo sapiens (human),Kd, 25
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50, 2000
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Cytochrome P450 2C9,Homo sapiens (human),IC50,>10000
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 1650
Sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 715
Temazepam,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1,Translocator protein,Homo sapiens (Human),IC50, 15995580286.15
Temazepam,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1,Serum albumin,Homo sapiens,Kd, 69183
Temazepam,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1,Translocator protein,Homo sapiens (Human),IC50, 17988709151.29
Temazepam,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 350
Lormetazepam,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1Cl,Translocator protein,Homo sapiens (Human),IC50, 3499451670.28
Lormetazepam,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1Cl,Liver fatty acid binding protein (rat L-FABP),Rattus norvegicus (Rat),Ki, 12900
Lormetazepam,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1Cl,Translocator protein,Homo sapiens (Human),IC50, 15995580286.15
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Adenosine receptor A3,Homo sapiens (human),IC50, 12
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Translocator protein,Homo sapiens (Human),IC50, 619441075077
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA receptor alpha-6/beta-2/gamma-2 subunit,Rattus norvegicus (Rat),Ki, 2.1
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA,na,Ki, 1000
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA A receptor alpha-1/beta-1/gamma-2,Homo sapiens (Human),Kd, 36
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA receptor alpha-1/beta-2/gamma-2 subunit,Homo sapiens (Human),Ki, 12
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Peripheral-Type Benzodiazepine Receptor,Rattus norvegicus (rat),Kd, 1.1
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA A receptor alpha-1/beta-1/gamma-2,Homo sapiens (Human),Ki, 750
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA receptor alpha-2/beta-3/gamma-2 subunit,Homo sapiens,Ki, 6.6
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Liver fatty acid binding protein (rat L-FABP),Rattus norvegicus (Rat),Ki, 531
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA receptor alpha-3/beta-2/gamma-2 subunit,Rattus norvegicus (Rat),Ki, 14
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Translocator protein,Homo sapiens (Human),IC50, 9397233105.65
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 7
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A)),Homo sapiens (Human),Kd, 23
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 0.41
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Peripheral-Type Benzodiazepine Receptor,Rattus norvegicus (rat),Ki, 13.6
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA receptor alpha-3/beta-2/gamma-2 subunit,HUMAN,Ki, 10
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki,>10000
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA receptor alpha-5/beta-3/gamma-2 subunit,Homo sapiens (Human),Ki, 11
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Cholecystokinin receptor,RAT,IC50,>100000
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA receptor gamma-1 subunit,Rattus norvegicus,IC50, 5
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA A receptor alpha-6/beta-2/gamma-2,HUMAN,Ki,>7000
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA(A) receptor subunit alpha-2,Rattus norvegicus (Rat),Ki, 4.8
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Translocator protein,Homo sapiens (Human),IC50, 5495408738.58
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Serum albumin,Rattus norvegicus,Kd, 1.5
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Peripheral-Type Benzodiazepine Receptor,Rattus norvegicus (rat),Kd, 213
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA receptor alpha-2/beta-2/gamma-2 subunit,Rattus norvegicus (Rat),Ki, 20
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA A receptor alpha-3/beta-2/gamma-2,HUMAN,Ki, 17
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Translocator protein,Homo sapiens (Human),Kd, 6
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Aldo-keto reductase family 1 member C1,Homo sapiens (human),IC50, 5600
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA A Alpha2Beta1Gamma2,Homo sapiens (Human),Ki, 16.9
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA A receptor alpha-3/beta-2/gamma-2,RAT,Ki, 13.9
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Serum albumin,Homo sapiens,Kd, 24547
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA receptor alpha-5/beta-3/gamma-2 subunit,Rattus norvegicus (Rat),Ki, 11
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,"17-beta-Hydroxysteroid Dehydrogenase 5 (17-beta-HSD5, AKR1C3)",Homo sapiens (human),IC50, 84000
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Cholecystokinin,RAT,Ki,>10000
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Translocator protein,Homo sapiens (Human),IC50, 39994474976.11
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Translocator protein,Homo sapiens (Human),IC50, 8090958991.78
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Peripheral-Type Benzodiazepine Receptor,Rattus norvegicus (rat),IC50, 520000
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA receptor alpha-3/beta-3/gamma-2 subunit,HUMAN,Ki, 15
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA A receptor alpha-5/beta-3/gamma-2,RAT,Ki, 9.8
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Peripheral-type benzodiazepine receptor,Mus musculus,IC50, 10
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Cholecystokinin A receptor,Cavia porcellus,IC50,>100000
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Aldo-keto reductase family 1 member C2,Homo sapiens (human),IC50, 2400
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA,na,Ki, 18
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA receptor alpha-1/beta-3/gamma-2 subunit,Homo sapiens (Human),Ki, 13
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,DOPAMINE,RAT,Ki,>10000
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA receptor alpha-1/beta-2/gamma-2 subunit,Rattus norvegicus (Rat),Ki, 12
Diazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,GABA receptor alpha-6/beta-3/gamma-2 subunit,HUMAN,Ki,>3000
Fludiazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,Translocator protein,Homo sapiens (Human),IC50, 1599558028.61
Fludiazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,Cholecystokinin receptor,Homo sapiens (human),IC50,>100000
Fludiazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,GABA A receptor alpha-3/beta-2/gamma-2,HUMAN,Ki, 205
Fludiazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,Translocator protein,Homo sapiens (Human),IC50, 13995873225.73
Fludiazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,Cholecystokinin receptor,RAT,IC50, 42000
Fludiazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,Translocator protein,Homo sapiens (Human),IC50, 1999861869.63
Fludiazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,Translocator protein,Homo sapiens (Human),IC50, 3597493351.56
Fludiazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,Translocator protein,Homo sapiens (Human),IC50, 4102041029.87
Fludiazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,GABA A Alpha2Beta1Gamma2,Homo sapiens (Human),Ki, 236
Fludiazepam,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,Translocator protein,Homo sapiens (Human),IC50, 24490632418.45
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,"Cholinergic, Nicotinic Alpha6",Chick,Ki, 20
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Homo sapiens (Human),Ki, 450
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,"Cholinergic, Nicotinic Alpha3Beta2",HUMAN,Ki, 220
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-3/beta-4 subunit,HUMAN,Ki, 260
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,"Cholinergic, Nicotinic Alpha6Beta4",Chick,Ki, 98
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Nicotinic acetylcholine receptor alpha2/beta4,Homo sapiens (Human),EC50, 10000
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor subunit alpha-2,Rattus norvegicus (Rat),Ki, 12
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Acetylcholine receptor protein alpha/beta/delta/gamma chain,Torpedo californica,IC50, 100
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Adrenaline alpha1,RAT,Ki, 64300
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-3/beta-2 subunit,Rattus norvegicus (Rat),Ki, 47
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-7 subunit,Homo sapiens (human),Ki, 2000
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor subunit alpha-4,Homo sapiens (human),Ki, 1
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-2/beta-2 subunit,Rattus norvegicus (Rat),Ki, 12
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,"Cholinergic, Nicotinic Alpha6Beta3Beta4Alpha5",RAT,Ki, 156
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Cytochrome P450 2A6,Homo sapiens (Human),IC50,>4.00e+5
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Rattus norvegicus (Rat),Ki, 17
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,n-AChR,RAT,Ki, 0.96
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-2/beta-4 subunit,Rattus norvegicus (Rat),Ki, 110
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Muscarinic acetylcholine receptor,RAT,IC50, 5800
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Cytochrome P450 2A6,Homo sapiens (Human),IC50, 580000
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Cytochrome P450 2A5,Mus musculus,IC50, 159956
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Cytochrome P450 3A,Homo sapiens (human),IC50, 1.424e+5
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-2 subunit/subunit beta-4,HUMAN,Ki, 70
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Adrenaline alpha2,RAT,Ki, 50500
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Acetylcholine receptor,Torpedo californica,EC50, 160000
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Choline transporter,Mus musculus,Ki, 520115.74
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Voltage-gated potassium channel,Homo sapiens (human),IC50, 245470.89
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor subunit alpha-3,Rattus norvegicus (Rat),Ki, 47
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor subunit alpha-2,Rattus norvegicus (Rat),Ki, 3.6
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,alpha-1 Nicotinic AChR,Homo sapiens (Human),EC50, 180000
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,"Cholinergic, Nicotinic Muscle",RAT,Ki, 1000
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor,Rattus norvegicus (Rat),Ki, 0.94
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Acetylcholine receptor protein alpha chain/beta chain/delta chain /gamma chain,Homo sapiens (Human),Ki, 5500
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-7 subunit,Homo sapiens (human),Kd, 1.06
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Cytochrome P450 2A6,Homo sapiens (Human),Kd, 470000
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor subunit alpha-3,Rattus norvegicus (Rat),Ki, 47
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Rattus norvegicus (Rat),Ki, 33
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Cytochrome P450 2A13,Homo sapiens (Human),Kd, 54000
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Serotonin 3a (5-HT3a)/3b (5-HT3b)/3c (5-HT3c)/3d (5-HT3d)/3e (5-HT3e) receptor,Homo sapiens (Human),Ki, 71000
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Cytochrome P450 2A6,Homo sapiens (Human),IC50, 2.63e+4
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,"Cholinergic, Nicotinic Alpha1Beta1DeltaGamma",RAT,Ki,>10000
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Acetylcholine Binding protein,Aplysia Californica,Ki, 280
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Cytochrome P450 2A6,Homo sapiens (Human),IC50,>4.00e+5
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Homo sapiens (Human),Ki, 29
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Cytochrome P450 1A,Homo sapiens (human),IC50, 4100000
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Rattus norvegicus (Rat),Ki, 1
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor,Rattus norvegicus (Rat),Ki, 1190
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-4 subunit,HUMAN,Ki, 23
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,"Cholinergic, Nicotinic Alpha3Beta2",HUMAN,Ki, 14
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-4 subunit,Rattus norvegicus (Rat),Ki, 40
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Rattus norvegicus (Rat),Ki, 0.84
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-7 subunit,Homo sapiens (human),Kd, 1.06
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Nicotinic Alpha-Bungarotoxin,Bungarus multicinctus,Ki, 900
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Rattus norvegicus (Rat),Ki, 30
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Muscarinic acetylcholine receptor,RAT,IC50, 28000
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,L&#8208;Hydroxynicotine oxidase (LHNO),Arthrobacter nicotinovorans,Kd, 4.600e+6
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor,Rattus norvegicus (Rat),Ki, 0.84
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Rattus norvegicus (Rat),Ki, 360
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,nAChR alpha4 beta2 subtype,Rattus norvegicus (Rat),Ki, 1.5
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Acetylcholine Binding protein,Lymnaea stagnalis,Kd, 40.7
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,n-AChR,RAT,Ki, 3
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor subunit beta-4,Rattus norvegicus (Rat),Ki, 73
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,"Cholinergic, Nicotinic Muscle",RAT,Kd, 5
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Cytochrome P450 2A5,Mus musculus,IC50, 160000
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-7 subunit,Mus musculus,Ki, 244
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Acetylcholine receptor protein alpha/beta/delta/gamma chain,Torpedo californica,Ki, 6270
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Sigma,HUMAN,IC50,>10000
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Acetylcholine Binding protein,Lymnaea stagnalis,Ki, 83
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Voltage-gated potassium channel,Homo sapiens (human),IC50, 244300
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-3/beta-2 subunit,Rattus norvegicus (Rat),Ki, 1
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor subunit alpha-4,Homo sapiens (human),EC50, 4700
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Transient receptor potential cation channel subfamily A member 1,Homo sapiens (Human),EC50, 17000
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Rattus norvegicus (Rat),Ki, 38
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-7 subunit,Homo sapiens (human),Ki, 9700
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-2/beta-2 subunit,Homo sapiens (Human),Ki, 5.5
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,n-AChR,RAT,Ki, 1.5
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-3/beta-2 subunit,Homo sapiens (Human),Ki, 29
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,"Cholinergic, Nicotinic Alpha6Beta2",Chick,Ki, 131
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-3/beta-4 subunit,Rattus norvegicus (Rat),Ki, 440
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor; alpha2/beta2,HUMAN,Ki, 9900
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,Neuronal acetylcholine receptor protein alpha-4/beta-2 subunit,Homo sapiens (Human),Ki, 0.600000
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Histamine H1 receptor,Homo sapiens (human),Kd, 0.087
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Adrenergic receptor alpha-2,Homo sapiens (Human),Ki, 230
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 300
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 192
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 4
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 10
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 185
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,DRD2,BOVINE,IC50, 20
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 2.1
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Voltage-gated potassium channel,Homo sapiens (human),Ki, 36000
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Dopamine receptor,Rattus norvegicus (Rat),Ki, 39
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),IC50, 20
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 203
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 1.9
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 22
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 610
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Histone H1,Homo sapiens (Human),Ki, 2
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki,>10000
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 25.1
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Histamine H1 receptor,Homo sapiens (human),Ki, 6
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Dopamine receptor,RAT,Ki, 50
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,DOPAMINE,RAT,Ki, 20
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 119
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Histamine H1 receptor,RAT,Ki, 0.3
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Transporter,Rattus norvegicus (rat),Ki, 2000
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Adrenergic receptor alpha-1,Homo sapiens (Human),Ki, 60
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Voltage-gated potassium channel,Homo sapiens (human),IC50, 12589.25
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Norepinephrine Monoamine transporters,Rattus norvegicus,Ki, 958
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Histamine H1 receptor,Homo sapiens (human),Ki, 87
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 66
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 5
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 39
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 82
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Muscarinic receptor M1 and M2,RAT,Ki, 22
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 2.8
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 60
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 26
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 9
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Alpha adrenergic receptor 1A and 1B,Rattus norvegicus (rat),Ki, 69
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 2.1
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 395
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 7.0
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 28
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Histamine H1 receptor,Homo sapiens (human),Ki, 22
Olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Voltage-gated potassium channel,Homo sapiens (human),IC50, 11481.54
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,HTR6,RAT,Ki, 15
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 11
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 50
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,neutrophil cytosolic factor 1,Homo sapiens,IC50, 50000
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Serotonin 3a (5-HT3a)/3b (5-HT3b) receptor,RAT,Ki, 39
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Dopamine D1 receptor,Mus musculus (Mouse),Ki, 16
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 15
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 300
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 9.4
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 18
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 290
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 150
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 2
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 79.9
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 2
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 1.69
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 28
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Dopamine D2 receptor,Mus musculus (Mouse),Ki, 7.6
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Dopamine receptor,RAT,Ki, 12
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 122
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Histamine H1 receptor,RAT,IC50, 1000
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 19
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 3.7
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 63.9
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 4.3
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Histamine H1 receptor,Homo sapiens (human),Ki, 7.76
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Histamine receptor (H4),Homo sapiens (human),Ki, 5012
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 500
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 20
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 3.6
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Histamine receptor (H4),Homo sapiens (human),Kd, 10.7
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 300
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,DRD2,GUINEA PIG,Ki, 16
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 6
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Histamine H1 receptor,Homo sapiens (human),Ki, 4.9
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 150.8
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,HTR6,RAT,Ki, 6
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 58
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Sulfotransferase 1A1 (SULT1A1),Homo sapiens (Human),Ki, 3.5e+4
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 11
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 1.77
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 221
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 87.2
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,HTR7,GUINEA PIG,Ki, 186.2
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 2
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 1
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,5-HT1,Homo sapiens (human),Ki, 2941.17
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Histamine receptor (H4),Homo sapiens (human),Ki, 3981
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 5.2
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 2
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 2456
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 4.5
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 4310
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Sulfotransferase 2A1 (SULT2A1),Homo sapiens (Human),Ki, 1.25e+5
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Dopamine receptor,RAT,Ki, 92
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Twik-RElated Potassium (K+) channel 1 (TREK1),Homo sapiens (Human),IC50, 20000
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 107.6
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,CHRM5,Homo sapiens,Ki, 241
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 16
Loxapine,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 7.94
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki,>10000
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Serotonin 3a (5-HT3a)/3b (5-HT3b)/3c (5-HT3c)/3d (5-HT3d)/3e (5-HT3e) receptor,Homo sapiens (Human),IC50, 1413
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 3.8
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,HTR6,MOUSE,Ki, 19.95
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 55
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 1.7
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,CHRM5,RAT,IC50, 1900
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Alpha-1A adrenergic receptor,Homo sapiens (Human),Kd, 251
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,DOPAMINE,RAT,Ki, 1420
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 0.4
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 0.36
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 0.63
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Histamine H1 receptor,RAT,IC50, 0.006000
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Serotonin (5-HT) receptor,Homo sapiens,EC50, 37.77
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Histamine H2 receptor,Cavia porcellus (domestic guinea pig),IC50, 880
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,HTR3A,Mus musculus (house mouse),Ki, 300
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,HTR2C,CANINE,Ki, 2.8
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,adrenergic Alpha2,RAT,Ki, 40
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,HTR6,MOUSE,Ki, 3.24
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,DRD2,BOVINE,Ki, 620
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Serotonin 1B/1D receptor,Rattus norvegicus (Rat),Ki, 2801
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Dopamine receptors; D2 & D4,Homo sapiens (Human),IC50, 3311.31
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 828
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Muscarinic receptor M2 and M3,RAT,Ki, 151.36
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,DRD1,BOVINE,Ki, 318
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Serotonin 3a (5-HT3a)/3b (5-HT3b) receptor,RAT,Ki, 70
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Norepinephrine transporter,RAT,Ki, 26.92
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,HTR7,GUINEA PIG,Ki, 100
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Serotonin (5-HT) receptor,HUMAN,Ki, 12.58
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Histamine H1 receptor,Homo sapiens (human),Ki, 1.7
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki,>10000
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 4.8
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Histamine H1 receptor,RAT,Ki, 1
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Norepinephrine Monoamine transporters,Rattus norvegicus,Ki, 26
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Histamine H1 receptor,Homo sapiens (human),Ki, 0.36
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 56
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 5.2
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 1.4
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 54.95
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 2197
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 1.5
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 426
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 47.86
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Dopamine receptor,Rattus norvegicus (Rat),Ki, 1524
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 1274
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Histamine receptor (H4),Homo sapiens (human),Ki, 750
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Sphingosine 1-Phosphate Receptor 3,Homo sapiens (human),EC50,>40000
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,HTR1D,RAT,Ki, 30.19
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Serotonin 1B/1D receptor,Rattus norvegicus (Rat),Ki, 4700
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 1.58
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 1000
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 4.3
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki,>500
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,adrenergic Alpha2,BOVINE,Ki, 17
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Adrenergic receptor alpha-2,NEONATAL RAT,Ki, 14
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 398.1
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,DRD1,CANINE,Ki, 161
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 27
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,5-hydroxytryptamine receptor 2B (5HT2B),Mus musculus (Mouse),Ki,>10000
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 4000
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Cerebral cortex alpha adrenergic receptor,CALF,Ki, 43
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,ADRA2C,OPOSSUM,Ki, 4.5
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50, 0.07
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 9400
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,HTR6,RAT,Ki, 39.81
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,ADRA2C,OK,Ki, 5.1
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,5-hydroxytryptamine receptor 7 (5HT7),Mus musculus (Mouse),Ki, 100
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,5-hydroxytryptamine receptor 1D,Homo sapiens (human),IC50, 380.19
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 674
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Serotonin receptor 2a and 2b (5HT2A and 5HT2B),RAT,Ki, 50.11
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>1000
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 12.02
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,HTR2C,PIG,Ki, 10
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 2841
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 55
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 71
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,HTR6,RAT,Ki, 38
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 1.58
Mianserin,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21,HTR1F,MOUSE,Ki, 100
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 130000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 916
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Cytochrome P450 2D6 (2D6),Homo sapiens (Human),IC50, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 266000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Monoamine oxidase,Rattus norvegicus (rat),Ki,>10000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 8300
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Cytochrome P450 1A,Homo sapiens (human),IC50, 5300
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Cytochrome P450 3A,Homo sapiens (human),IC50, 440
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Neurokinin 1 receptor,Rattus norvegicus (rat),Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,"Nitric-oxide synthase, brain",Rattus norvegicus (rat),Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Inositol Triphosphate,RAT,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Alpha adrenergic receptor 1A and 1B,Rattus norvegicus (rat),Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Adrenergic receptor beta,Rattus norvegicus (Rat),Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 8.3
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,SOMATOSTATIN,RAT,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 31700
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 18400
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Serotonin (5-HT) receptor,Homo sapiens,Ki, 3733
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Ecto-5&#39;-nucleotidase (e5&#39;NT),Rattus norvegicus (Rat),Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Serotonin (5-HT) receptor,HUMAN,Ki, 4447
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Adenosine receptor A1,Rattus norvegicus (rat),Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Transporter,Rattus norvegicus (rat),Ki, 16
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki,>10000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 63900
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,ADRB2,Rattus norvegicus,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium (Site 2),Rattus norvegicus,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Renal Outer Medullary Potassium (ROMK),Rattus norvegicus (Rat),Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 230
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Calcium channel,RAT,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Glutamate kainate,RAT,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 369.2
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 920000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Voltage-gated potassium channel beta subunit Mink/subunit Kv7.1,Homo sapiens,IC50, 10000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Histamine H1 receptor,Homo sapiens (human),Ki, 2300
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Potassium Channel (Ca2+ dependent),RAT,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Protein kinase C,MOUSE,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Cytochrome P450 2C9,Homo sapiens (human),IC50, 29000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 163500
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 953
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Voltage-gated potassium channel subunit Kv4.3,Homo sapiens,IC50, 100000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 550
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium (Site 1),Rattus norvegicus,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Neuropeptide Y receptor type 1,HUMAN,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 353000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki,>10000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 554000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Norepinephrine transporter,RAT,Ki, 15.9
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Adenosine transporter,RAT,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,GABA A,BOVINE,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 18
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 2261
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Voltage-gated potassium channel,Homo sapiens (human),IC50, 5012
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Glutamate-NMDA,RAT,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Histamine H3 receptor,Rattus norvegicus (rat),Ki,>5000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 0.07
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,TACR2,mouse,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 97100.0
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Calcium channel (Type N),na,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,HTR4,GUINEA PIG,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Cholecystokinin receptor,MOUSE,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 504
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 0.2
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 5000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 1060
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Histamine H2 receptor,Cavia porcellus (domestic guinea pig),Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 240500
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,"Glycine, non-strychnine",RAT,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 2402
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 2.5
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Adenylate cyclase Forskolin,RAT,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Monoamine Oxidase Type B (MAO-B),Rattus norvegicus (rat),Ki,>10000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Neurokinin 3 receptor,mouse,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 3660
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 1.17
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,GRIA3,RAT,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 240
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Nicotinic Alpha-Bungarotoxin,Bungarus multicinctus,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 8.8
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Cytochrome P450 2C19,Homo sapiens (human),IC50, 4100
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Transporter,Rattus norvegicus (rat),Ki, 3
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Norepinephrine transporter,RAT,Ki, 3
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 2814000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki, 3959
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,ADRA2B,MOUSE,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,DOPAMINE,RAT,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Voltage-gated sodium channel subunit Nav1.5,Homo sapiens (Human),IC50, 7943
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 4720
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,ADENOSINE A2,BOVINE,Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 3549
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 9600
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 5.97
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 0.5
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki, 3000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 7275000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 659.3
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 2100
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Histamine receptor (H3),Homo sapiens (human),Ki,>5000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 61.3
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 235500
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 419
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 1000
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Calcium channel (Type L),HUMAN,IC50, 25119
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Histamine H1 receptor,RAT,Ki, 3200
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki,>10000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki,>10000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,HTR2C,Beef,Ki, 154.88
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 410
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 812
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Cytochrome P450 2C19,Homo sapiens (human),IC50, 40
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Voltage-gated potassium channel,Homo sapiens (human),IC50, 2290.87
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Histamine receptor (H3),Homo sapiens (human),Ki, 6633
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 91.2
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,HTR2C,Beef,Ki, 269.15
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 3661
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Kd, 240
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 784
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 590
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 1.9
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 760
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Histamine receptor (H3),Homo sapiens (human),Ki, 2.7
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,CHRM5,Homo sapiens,Ki, 2200
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 1.47
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 7.7
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 295.12
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 5030
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 3900
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 1528
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Histamine receptor (H3),Homo sapiens (human),Ki, 7300
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 30.9
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 8.3
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 23.98
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 141
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Cytochrome P450 2C8,Homo sapiens (Human),Ki, 294000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 1200
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin 1B/1D receptor,Rattus norvegicus (Rat),Ki, 6165.95
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 72
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 14
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 998
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serum albumin,Rattus norvegicus,Kd, 3.6
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 1353
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 30.8
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,SLC6A3,MOUSE,Ki, 11
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 26
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki,>10000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 1000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,ADRB2,Rattus norvegicus,Ki,>10000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 702
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Calcium channel,RAT,IC50, 2820
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 2600
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 1426
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki,>10000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 117.48
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),IC50,>1000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Norepinephrine Monoamine transporters,Rattus norvegicus,Ki, 143
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 2900
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Sigma,HUMAN,IC50, 851
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,CHRM5,Homo sapiens,Ki, 2700
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Cytochrome P450 2J2,Homo sapiens (Human),IC50,>50000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 1000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Histamine H1 receptor,Homo sapiens (human),Ki,>10000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 5063
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Transporter,Rattus norvegicus (rat),Ki, 158
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 1659.58
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 7490
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Histamine H1 receptor,Homo sapiens (human),Ki, 1100
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,HTR1D,Bos taurus (Bovine),Ki, 4265.79
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin 1B/1D receptor,Rattus norvegicus (Rat),Ki, 3388.44
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 3090
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 1
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki,>10000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 616.59
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Twik-RElated Potassium (K+) channel 1 (TREK1),Homo sapiens (Human),EC50, 9000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,HTR6,RAT,Ki, 1770
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,HTR1D,Bos taurus (Bovine),Ki,>10000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Norepinephrine transporter,RAT,Ki, 4997
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Acetylcholinesterase,Homo sapiens (human),IC50, 130
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Voltage-gated potassium channel,Homo sapiens (human),IC50, 457.09
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 933
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,ubiquitin-conjugating enzyme E2 N,Homo sapiens,IC50,>20000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,HTR1D,Bos taurus (Bovine),Ki, 3890.45
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin (5-HT) receptor,RAT,Ki,>10000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin 1B/1D receptor,Rattus norvegicus (Rat),Ki,>10000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 147.91
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 1.4
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,adrenergic Alpha2,RAT,Ki, 2800
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 10
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Potassium voltage-gated channel subfamily C member 1,Rattus norvegicus,IC50, 800
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,HTR2C,PORCINE,Ki, 64
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki,>10000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Twik-RElated Potassium (K+) channel 1 (TREK1),Homo sapiens (Human),EC50, 19000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 3097
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin (5-HT) receptor,RAT,Ki,>10000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Norepinephrine transporter,MOUSE,Ki, 85
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 810
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Potassium voltage-gated channel subfamily C member 1,Rattus norvegicus,IC50, 13100
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Muscarinic receptor M2 and M3,RAT,Ki, 512
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Kd, 0.810
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,HTR2C,PORCINE,Ki, 72
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,HTR2C,Beef,Ki, 3630.78
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Norepinephrine transporter,RAT,Ki, 85.3
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Serotonin (5-HT) receptor,RAT,Ki,>10000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50,>1000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,DOPAMINE,RAT,Ki,>10000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Twik-RElated Potassium (K+) channel 1 (TREK1),Homo sapiens (Human),IC50, 9000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Twik-RElated Potassium (K+) channel 1 (TREK1),Homo sapiens (Human),IC50, 14000
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 420
Fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Kd, 3600
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,Homo sapiens (human),Ki, 0.67
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenergic Alpha,HUMAN,IC50, 16900
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Neurotrophic tyrosine kinase receptor,Homo Sapiens,Kd, 1800000
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Calcium channel,RAT,IC50, 3750
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 0.17
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 37
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET,Homo sapiens (Human),IC50, 1500
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 2000
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine receptor (H4),Homo sapiens (human),Ki, 33.6
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,CHRM5,Homo sapiens,Ki, 97
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 21
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Serum albumin,Rattus norvegicus,Kd, 1.3
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 1140
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium channel protein type 7 subunit alpha,Homo sapiens,IC50, 20000
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 206
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Cytochrome P450 2D6 (2D6),Homo sapiens (Human),IC50, 2300
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,GABA transporter,Mus musculus,IC50, 169824
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 55
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium channel alpha subunit,Homo sapiens (Human),IC50, 1000
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50, 0.04
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Cytochrome P450 2D3,Rattus norvegicus,IC50, 14200
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine D5 receptor,Homo sapiens (Human),Ki, 170
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine transporter,RAT,Ki, 8.6
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,DOPAMINE,RAT,Ki, 81
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 41
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Cytochrome P450 2D18,Rattus norvegicus,IC50, 19300
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 84
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 65
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 50
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,Homo sapiens (human),Ki, 6.3
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 89
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET,Homo sapiens (Human),IC50, 10000
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Cytochrome P450 2D2,Rattus norvegicus,IC50, 1900
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 850
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,HTR6,MOUSE,Ki, 89.13
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 2500
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic receptor M2 and M3,RAT,Ki, 2.6
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 9.6
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,HTR6,RAT,Ki, 63.10
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 2030
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 2580
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-gated sodium channel subunit alpha Nav1.2 (Nav1.2),Homo sapiens (Human),IC50, 3100
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 16
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 114
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 8.5
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 214
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 4.3
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 18
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-gated potassium channel,Homo sapiens (human),IC50, 3280
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine receptor (H3),Homo sapiens (human),Ki,>1000
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-gated sodium channel subunit Nav1.5,Homo sapiens (Human),IC50, 1600
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,CHRM5,Homo sapiens,Ki, 15.7
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Cytochrome P450 2D1,Rattus norvegicus,IC50, 204000
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,adrenergic Alpha2,RAT,Ki, 340
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 5300
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,HTR6,RAT,Ki, 148
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,RAT,Ki, 4.1
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 12.8
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H2 receptor,Cavia porcellus (domestic guinea pig),IC50, 660
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 15
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 2.8
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki,>10000
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H2 receptor,Cavia porcellus (domestic guinea pig),IC50, 7000
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Cytochrome P450 2C8,Homo sapiens (Human),Ki, 49900
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 11
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 5
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 40
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 4.4
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 4.3
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-gated L-type calcium channel,Homo sapiens,IC50, 11600
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,ADRB2,Rattus norvegicus,Ki,>10000
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,RAT,Ki, 46
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 1.49
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET,Homo sapiens (Human),IC50, 1000
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,GABA transporter 1,Rattus norvegicus,IC50, 389000
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 196
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine transporter,RAT,Ki, 0.99
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 2570
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 300
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 60
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 13.3
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 450
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 7.2
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki,>10000
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 294
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine D2 receptor,Mus musculus (Mouse),Ki, 726
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki,>10000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,Ki, 0.65
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 160
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium channel protein type 7 subunit alpha,Homo sapiens,IC50, 3600
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 110
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 210
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,DRD1,BOVINE,Ki,>10000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenergic receptor beta,Rattus norvegicus (Rat),Ki,>10000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 0.13
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 2450
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic receptor M2 and M3,RAT,Ki, 320
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Calcium channel,RAT,IC50, 11700
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine Monoamine transporters,Rattus norvegicus,Ki, 12
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 942
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,Homo sapiens (human),Ki, 1.4
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,HTR6,RAT,Ki, 190
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 8500
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 20
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 3100
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,SLC6A4,MOUSE,Ki, 5
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine transporter,MOUSE,Ki, 8114
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,CHRM5,Homo sapiens,Ki, 143
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 112
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 244
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,Homo sapiens (human),Ki, 60
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,CHRM5,RAT,IC50, 300
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Cytochrome P450 2J2,Homo sapiens (Human),IC50,>50000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 8.7
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 106
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 94
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,HTR3A,Mus musculus (house mouse),Ki, 4402
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Multidrug and toxin extrusion protein 2,Homo sapiens,IC50,>100000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenergic Alpha,HUMAN,IC50, 56800
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 150
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-gated potassium channel,Homo sapiens (human),IC50, 3388
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 1379
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 520
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki,>10000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenaline alpha2,RAT,IC50, 9900
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H3 receptor,Rattus norvegicus (rat),Ki,>5000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 5465
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 0.15
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 1561
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 60
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,DRD2,BOVINE,Ki, 180
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenaline alpha1,RAT,IC50, 16000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Serum albumin,Homo sapiens,Kd, 851138
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-gated potassium channel,Homo sapiens (human),IC50, 1380.38
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki,>10000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,adrenergic Alpha2,RAT,Ki, 4600
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,RAT,Ki, 2
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 94
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 32
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-dependent L-type calcium channel subunit alpha-1C,Cavia porcellus,IC50, 1709
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 160
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 1000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 42
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,adrenergic Alpha2,RAT,Ki, 9200
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenergic Alpha,HUMAN,IC50, 17100
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 6400
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Solute carrier family 22 member 2,Homo sapiens,IC50, 600
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenergic Alpha,HUMAN,IC50, 27700
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 17.6
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,CHRM5,Homo sapiens,Ki, 83
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 300
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 102
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 620
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 16
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 0.49
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine transporter,RAT,Ki, 0.06
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenaline alpha1,RAT,Ki, 2800
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Pleiotropic ABC efflux transporter of multiple drugs,Saccharomyces cerevisiae S288c,IC50, 22000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H2 receptor,Cavia porcellus (domestic guinea pig),IC50, 1900
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 3780
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic receptor M2 and M3,RAT,Ki, 37
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Transporter,Rattus norvegicus (rat),Ki, 0.78
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 129
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,Homo sapiens (human),Ki, 16
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,HTR3A,Mus musculus (house mouse),Ki, 3651
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine transporter,BOVINE,Ki, 8.88
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,SLC6A3,MOUSE,Ki, 42
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 5800
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-gated L-type calcium channel,Homo sapiens,IC50, 8300
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Prion protein,Homo sapiens,EC50, 10000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,RAT,Ki, 124
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H2 receptor,Cavia porcellus (domestic guinea pig),IC50, 3800
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 4000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,SLC6A4,MOUSE,IC50, 9300
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Multidrug and toxin extrusion protein 1,Homo sapiens,IC50, 10000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-hydroxytryptamine receptor 2C (5HT2C),Mus musculus (Mouse),Ki, 160
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Calcium channel,RAT,IC50, 4050
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adrenaline alpha2,RAT,IC50, 10000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Voltage-gated sodium channel subunit Nav1.5,Homo sapiens (Human),IC50, 1520
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 387
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Kd, 0.83
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 66
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 149
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Adenosine receptor A3,Homo sapiens (human),IC50, 4.4
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 51
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine receptor (H3),Homo sapiens (human),Ki,>5000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 31
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,ADRB2,Rattus norvegicus,Ki,>10000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Cytochrome P450 2J2,Homo sapiens (Human),IC50,>50000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,DOPAMINE,RAT,Ki, 3000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 397.0
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 190
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine transporter,RAT,Ki, 11
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine transporter,BOVINE,Ki, 93.6
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki,>10000
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 350
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Norepinephrine transporter,MOUSE,Ki, 12
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 23
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.42
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki,>10000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 731
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki,>20000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1.57
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.090000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.14
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 174.83
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,OPRD1,Bos taurus,Ki, 2469
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 516.58
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.014
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 1704.16
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 203.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki,>20000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 4.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.092000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.54
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.220000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 2723
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.200000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 2571.83
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.180000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 16.21
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR Y313F),Homo sapiens (Human),Kd, 1.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 13.81
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.071000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 1295.55
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 1607.19
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,IC50, 3.5
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.15
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 348.08
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 3957.55
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 87.86
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 24.41
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 192.99
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR K227A),Homo sapiens (Human),Kd, 0.48
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid receptor,Rattus norvegicus (rat),Ki,>10000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid receptor,Rattus norvegicus (rat),Kd, 0.029
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.40
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.160000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 111.05
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.110000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 186.1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 110
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.360000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 19.8
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 6.69
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 557.54
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.74
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 6.5
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 3.66
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 2587
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),IC50, 5.5
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 48
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 165.88
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 56
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.410000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.094000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.086000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.150000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.360000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu opioid receptor,CALF,Ki, 1.83
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 269.62
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 43
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 2.95
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 2.11
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 4788.53
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.000000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 19
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 87.27
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.710000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 396
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 6.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.090000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.700000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 6.1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 35.56
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 19.26
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.390000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 20.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.029000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.044000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,IC50, 10
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.060000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.100000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 37.04
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR H291F),Homo sapiens (Human),Kd, 3.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 631.76
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.41
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 8.0
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.250000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.36
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 50.66
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 8.1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.47
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu opioid receptor,CALF,Ki, 0.23
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR I316A),Homo sapiens (Human),Kd, 2.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.340000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.680000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 27.41
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 312.15
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.77
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 189.66
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR E297A),Homo sapiens (Human),Kd, 0.98
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 2.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,"Nociceptin/Orphanin FQ, NOP receptor",MOUSE,Ki, 312
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 11
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 13
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),IC50, 20
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.04
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 64
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.100000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,IC50, 0.500000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR D138A),Homo sapiens (Human),Kd, 4.9
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 240
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 182.47
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 15.09
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.170000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),EC50, 3162
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 6.26
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.17
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 135.49
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,IC50, 3.1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 117.13
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 7.1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 36
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 159
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 31.61
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 4910
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),IC50, 9
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 2601
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.150000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.065000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 5250
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 16981.98
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.18
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid receptor,Rattus norvegicus (rat),Kd, 830
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.051000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 532
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 1602.42
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 3616.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,IC50, 2.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 569
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.29
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 35.04
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 79
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR Y66A),Homo sapiens (Human),Kd, 1.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.05
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 34
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 26
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 3.32
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 11
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,OPRD1,GUINEA PIG,Ki, 0.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 210.34
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 346.1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.280000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 62
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 544.34
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 4.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.320000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.086000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR M226A),Homo sapiens (Human),Kd, 1.9
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 3.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,MOUSE,Ki, 127
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.04
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.130000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 2.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 4.40
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 22
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 2.55
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.12
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 1983.26
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 5783
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.210000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 2.9
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 53
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,OPRD1,GUINEA PIG,Ki, 39.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),IC50, 36
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 773.56
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 67.22
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1.1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.09
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 15.01
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.560000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.22
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 2.01
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR Y320A),Homo sapiens (Human),Kd, 3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 13.09
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR Y312F),Homo sapiens (Human),Kd, 1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.17
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,IC50, 2.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.600000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 55.53
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 282.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.078000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.08
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 44.28
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.047000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1.11
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.480000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu opioid receptor,CALF,IC50, 1.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 2.75
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 112.07
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.46
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.120000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1.5
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 2.55
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.160000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.160000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.15
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 60.54
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),IC50, 13
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki,>2.0e+4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 4.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 176.92
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 7.22
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 2.1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.47
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 18.82
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),IC50, 1.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.029000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR L212A),Homo sapiens (Human),Kd, 1.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 2807
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 17.54
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 77
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1.71
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.990000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.150000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 183
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 47.06
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 775.19
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 26
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 23.11
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 5.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.04
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.240000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki,>2.0e+4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 4.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.043000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 444.54
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.210000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 163.30
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 2.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 341.52
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki,>20000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 6176
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Kd, 1.1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.290000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 230
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),IC50, 25
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.230000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.29
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.310000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.070000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 49.88
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 524
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 109.39
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.91
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.240000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.090000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR Y139A),Homo sapiens (Human),Kd, 3.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 6.63
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.220000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.26
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.29
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 122
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.051000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.330000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.860000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.51
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.8
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 823.29
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 2.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid receptors; mu & delta,Rattus norvegicus (rat),IC50, 250
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 2.60
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.190000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 19.04
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.07
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 13.52
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.370000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),IC50, 2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.600000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 1005.26
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR Y119A),Homo sapiens (Human),Kd, 2.8
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.21
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 1.8
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.59
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 1455
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.140000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.08
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 147
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 1165.91
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1031.97
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.600000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,OPIATE Kappa 3,CALF,Ki, 536
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 4555.05
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 341.38
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),IC50, 2.9
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.210000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.420000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 1004.92
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.23
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.07
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 5.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 83.8
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.19
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 10.13
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 133
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 56
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,IC50, 1.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.100000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid receptors; mu & delta,Rattus norvegicus (rat),Kd, 100
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>10000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 1489.98
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.15
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 8.9
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.29
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 143500
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.067000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid receptor,Rattus norvegicus (rat),Ki, 12.9
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 2796.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 669.56
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki,>20000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.033000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 2.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.041000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.100000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.052000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 10.57
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.069000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 163.53
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 2.70
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 14.98
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 17
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 39.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 37.54
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.025000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 122.30
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Norepinephrine transporter,RAT,Ki,>10000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 4407.89
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.93
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR M142A),Homo sapiens (Human),Kd, 4.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 926.92
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,OPRD1,Bos taurus,Ki, 1000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 332.93
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki,>20000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 51.45
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 242800
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.12
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 35.09
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.53
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR Y313A),Homo sapiens (Human),Kd, 5.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 892.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),IC50, 6.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 34
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 2.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,IC50, 1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 24.29
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 757
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.110000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 170
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 497.73
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 148.9
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.390000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 4630
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.25
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 1116.98
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 2.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.880000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.240000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.200000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),EC50, 21
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 130.0
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.110000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 64.53
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki,>20000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 25
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),EC50, 1.9
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,IC50, 1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 26.28
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),IC50, 48
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.15
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.270000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 10616.52
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 17
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 404.33
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 51.10
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.8
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 3358
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),IC50, 6.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.490000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.340000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.14
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.120000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.130000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 145.03
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu opioid receptor,CALF,Ki, 1.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 544.71
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1.25
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 39
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.55
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 5811
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 739.45
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),IC50, 12
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.120000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 17
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.72
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,MOUSE,Ki, 0.03
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 2.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 242.28
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),IC50, 11
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.054000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 820
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki,>10000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 2.55
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.120000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.086000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR H291A),Homo sapiens (Human),Kd, 5.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 7124.13
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.890000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 4.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 9.9
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1253.71
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.067000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.06
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1.000000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 27
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 3254.47
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR Q115A),Homo sapiens (Human),Kd, 1.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 77.94
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.038000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,IC50, 0.300000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.160000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 47.27
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 11
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.057000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 16
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.12
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 218.1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.300000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 1054.82
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 2.30
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 77
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 13.8
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 1.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 4.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 5.9
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.13
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,OPRD1,GUINEA PIG,Ki, 1.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 215.94
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),IC50, 19
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.28
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 5.5
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.059000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.800000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 9.01
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 72.98
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.074000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.06
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.08
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 13803.96
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.190000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),IC50, 13
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 54.83
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 7.79
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 6.72
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 157.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.9
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 25
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 121
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 261.93
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.210000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 1862.14
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,IC50, 6.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 79.55
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.480000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.067000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.400000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 25.8
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 4.51
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 2425.67
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 4.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki,>10000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu opioid receptor,CALF,Ki, 11.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.53
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 47.12
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.500000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,MOUSE,EC50, 3.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),EC50, 85.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.35
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 2763
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 4.16
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.400000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.820000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 8.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 28
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1.06
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 575.98
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.10
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 29.43
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,OPIATE Kappa 3,CALF,Ki, 148
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR D138N),Homo sapiens (Human),Kd, 2.0
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 4.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.880000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR Y312A),Homo sapiens (Human),Kd, 0.71
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.27
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.091000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 147.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Kd, 0.200000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.120000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 383.41
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 1.5
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 8.33
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 165.12
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 15.72
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,IC50, 6.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.240000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.150000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,OPIATE Sigma,RAT,Ki,>10000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.140000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.18
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 201.54
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.470000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 2.0
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,OPIATE Kappa 3,CALF,Ki, 33.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.120000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.200000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR I294A),Homo sapiens (Human),Kd, 3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.082000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 4.0
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 3024.75
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 395
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 355.13
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 147.99
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 9.55
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 42.46
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,IC50, 2.9
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 3.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 105
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.030000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 12
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.020000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),IC50, 30
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.560000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 56
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 228.55
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 20.48
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 10074.56
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.74
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.160000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.33
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.210000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 8830
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 56.86
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.150000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 1034.67
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.900000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR I135A),Homo sapiens (Human),Kd, 0.95
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.09
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR Y320F),Homo sapiens (Human),Kd, 1.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 8.69
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.060000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.35
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 0.600000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),EC50, 1.84
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Voltage-gated potassium channel,Homo sapiens (human),IC50, 7585.78
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR K200A),Homo sapiens (Human),Kd, 1.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 5.02
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 26.92
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.05
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,IC50, 0.700000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 2.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.200000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 240
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 313.8
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 6.1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 1898.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.620000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.470000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 1.91
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 56.98
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),IC50, 1.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.76
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 246.9
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 3.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 493.55
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.031000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 15.81
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 883.98
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Voltage-gated potassium channel,Homo sapiens (human),IC50, 7943.28
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 2595
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid receptors; mu & delta,Rattus norvegicus (rat),IC50, 110
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 120
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 570.67
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.20
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1.07
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 16.03
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.110000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.230000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.015000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),EC50, 950
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 349.03
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki,>20000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 79
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Opioid growth factor receptor-like protein 1,Homo sapiens (Human),Ki, 9605.70
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.190000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.59
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 8.5
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 167.5
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 438.88
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,OPRD1,Bos taurus,Ki, 35.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 25.38
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 34
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 517.28
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 6.75
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.45
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 5.6
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.600000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.800000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.5
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.43
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 15
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.062000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.180000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 2.1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 21.97
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 4.5
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 12.89
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki,>20000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,IC50, 1.1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 3.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.190000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.19
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.57
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),IC50, 16
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 3.58
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 361.75
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR Y119F),Homo sapiens (Human),Kd, 1.9
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 32.24
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 849.99
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 4.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,&#954; opioid receptor (KOR Y139F),Homo sapiens (Human),Kd, 1.4
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.2
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 46
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 26
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 5530.06
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.019000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,Ki, 1.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.040000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,IC50, 1.7
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.3
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 68
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.40
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 5.35
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 653.9
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Kappa-type opioid receptor,Homo sapiens (human),Ki, 12.07
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 13
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin receptor,Homo sapiens (human),Ki, 80
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 1479.53
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.1
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.210000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.15
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.098000
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 1.5
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,Mu-type opioid receptor,Homo sapiens (human),Ki, 20
Buprenorphine,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,mu/kappa opioid receptor,GUINEA PIG,IC50, 16
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Voltage-gated potassium channel,Homo sapiens (human),IC50, 251189
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),IC50, 30
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Dopamine receptor,Rattus norvegicus (Rat),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Calcium channel,RAT,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Histamine H2 receptor,Cavia porcellus (domestic guinea pig),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Glutamate kainate,RAT,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 30
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),IC50, 149
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50, 126
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 519
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50, 300
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Potassium Channel (Ca2+ dependent),RAT,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 2230
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Adenosine transporter,HUMAN,Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Protein kinase C,MOUSE,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Monoamine Oxidase Type B (MAO-B),Rattus norvegicus (rat),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Adenosine transporter,RAT,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Norepinephrine transporter,RAT,Ki, 938
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Serum albumin,Rattus norvegicus,Kd, 5.1
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Neuropeptide Y receptor type 1,HUMAN,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 7.7
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 640
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,HRH1,BOVINE,Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Kd, 8.9
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Glutamate-NMDA,RAT,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50, 300
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),IC50, 61
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,ADENOSINE A2,BOVINE,Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium-dependent dopamine transporter,Homo sapiens (human),Kd, 9300
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,TACR2,mouse,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Cholecystokinin receptor,MOUSE,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Cannabinoid receptor 2,Homo sapiens (human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,ADRB2,Rattus norvegicus,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50, 60
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium (Site 2),Rattus norvegicus,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Transporter,Rattus norvegicus (rat),IC50, 640
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Norepinephrine Monoamine transporters,Rattus norvegicus,Ki, 220
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,GABA A,BOVINE,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Adenosine receptors; A1 & A2a,Homo sapiens (human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,"Glycine, non-strychnine",RAT,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,HTR3A,Mus musculus (house mouse),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Norepinephrine Monoamine transporters,Rattus norvegicus,Ki, 138
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 0.1
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium-dependent dopamine transporter,Homo sapiens (human),Kd, 3500
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,HTR4,GUINEA PIG,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,adrenergic Alpha2,RAT,Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Adenylate cyclase Forskolin,RAT,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Voltage-gated sodium channel subunit Nav1.5,Homo sapiens (Human),IC50, 199526
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Serotonin (5-HT) receptor,Homo sapiens,Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 240
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Kd, 1060
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 20
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 400
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 531.3
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,SLC6A3,GUINEA PIG,Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Neurokinin 3 receptor,mouse,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium (Site 1),Rattus norvegicus,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,DOPAMINE,RAT,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Nicotinic Alpha-Bungarotoxin,Bungarus multicinctus,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Monoamine oxidase,Rattus norvegicus (rat),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 2792
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Muscarinic receptor M2 and M3,RAT,Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 2070
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,GRIA3,RAT,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Norepinephrine transporter,RAT,Ki, 0.64
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium-dependent dopamine transporter,Homo sapiens (human),IC50, 4430
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,ADRA2B,MOUSE,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,"Nitric-oxide synthase, brain",Rattus norvegicus (rat),Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50, 1600
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Histamine H1 receptor,RAT,Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Neurokinin 1 receptor,Rattus norvegicus (rat),Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 2004
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Ecto-5&#39;-nucleotidase (e5&#39;NT),Rattus norvegicus (Rat),Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Adrenergic receptor beta,Rattus norvegicus (Rat),Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Kd, 30
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 1160
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Alpha adrenergic receptor 1A and 1B,Rattus norvegicus (rat),Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 4700
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,ADENOSINE A2,BOVINE,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Cannabinoid receptor 1,Homo sapiens (human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Adenosine receptor A1,Rattus norvegicus (rat),Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),IC50,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Renal Outer Medullary Potassium (ROMK),Rattus norvegicus (Rat),Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,HRH3,RAT,Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium-dependent dopamine transporter,Homo sapiens (human),IC50, 19600
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),IC50, 7
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,CHRM5,Homo sapiens,Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Calcium channel (Type N),na,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Voltage-gated potassium channel subunit Kv4.3,Homo sapiens,IC50, 5011872
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 2.8
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,CHRM5,Homo sapiens,Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Inositol Triphosphate,RAT,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Norepinephrine Monoamine transporters,Rattus norvegicus,IC50, 5800
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Kd, 1800
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,SOMATOSTATIN,RAT,Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Histamine H1 receptor,Homo sapiens (human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Histamine H2 receptor,Cavia porcellus (domestic guinea pig),Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 1000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki,>10000
Venlafaxine,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,Serotonin (5-HT) receptor,HUMAN,Ki,>10000
Agomelatine,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki,>10000
Agomelatine,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 630
Agomelatine,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 4466.83
Agomelatine,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1,Ribosyldihydronicotinamide dehydrogenase [quinone],Homo sapiens (Human),IC50, 43.65
Agomelatine,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1,Melatonin,GUINEA PIG,Ki, 0.09
Agomelatine,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1,Melatonin,RABBIT,Ki, 0.14
Agomelatine,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1,Melatonin receptor,Homo sapiens (Human),IC50, 2.51
Agomelatine,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1,Melatonin receptor,Homo sapiens (Human),IC50, 2
Agomelatine,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1,Melatonin receptor,Homo sapiens (Human),Ki, 0.03
Agomelatine,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1,HTR2C,PORCINE,Ki, 407.38
Agomelatine,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 257.04
Agomelatine,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1,Melatonin receptor,Homo sapiens (Human),IC50, 0.794
Agomelatine,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1,Melatonin receptor,Homo sapiens (Human),IC50, 0.794
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,HTR5A,RAT,Ki, 1000
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin receptor,Homo sapiens (Human),Ki, 1.12
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki,>10000
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki,>10000
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 42
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin,GUINEA PIG,Ki, 346.73
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin,RABBIT,Ki, 273
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin,RABBIT,Ki, 6.9
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin 1C,Xenopus,Ki, 1.86
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,HTR2C,PORCINE,Ki,>10000
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 5754.40
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin receptor,Homo sapiens (Human),Ki, 0.08
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin,Sheep,Ki, 3
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Acetylcholinesterase,Electrophorus electricus (Electric eel),IC50, 12500
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin receptor,Homo sapiens (Human),Ki, 1.67
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin,RABBIT,Ki, 0.37
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin,GUINEA PIG,Ki, 10.23
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 7.2
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin receptor,Homo sapiens (Human),Ki, 7.9
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin receptor,Homo sapiens (Human),IC50, 0.794
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 1000
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 840
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Tyrosinase,Mus musculus (Mouse),Ki, 240000
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,5-HT5B,RAT,Ki, 1000
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin receptor,Homo sapiens (Human),Ki, 18.8
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Butyrylcholinesterase (BChE),Equus caballus (Horse),IC50,>100
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin receptor,Homo sapiens (Human),IC50, 1.26
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin,GUINEA PIG,Ki, 0.24
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin receptor,Homo sapiens (Human),Ki, 0.54
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Ribosyldihydronicotinamide dehydrogenase [quinone],Homo sapiens (Human),IC50, 9900
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin,RABBIT,Ki, 3.2
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 4.1
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 2675
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Ribosyldihydronicotinamide dehydrogenase [quinone],Homo sapiens (Human),Ki, 28
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Acetylcholinesterase,Bos taurus (bovine),IC50,>100
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin receptor,Homo sapiens (Human),Ki, 79.43
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin receptor,Homo sapiens (Human),Ki, 6.6
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 16
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin,RABBIT,Ki, 460
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin,Chick,Ki, 0.70
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin receptor,Homo sapiens (Human),Ki, 3.5
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin,Sheep,Ki, 0.24
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 1.7
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 0.08
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Cytochrome P450 2C19,Homo sapiens (human),IC50,>30000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki,>10000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Rhodopsin kinase,Homo sapiens,IC50,>100000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,HTR1D,Bos taurus (Bovine),Ki, 4897.78
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki, 0.05
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Kd, 30000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,CHRM5,Homo sapiens,Ki, 650
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki,>10000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki,>10000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Kd, 0.13
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Neurokinin 1 receptor,Homo sapiens (human),IC50, 900
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 98
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,SLC6A3,MOUSE,Ki, 0.440000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Kd, 0.15
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Kd, 490
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki,>10000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,ADRB2,Rattus norvegicus,Ki,>10000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Norepinephrine Monoamine transporters,Rattus norvegicus,Ki, 33
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Kd, 40
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki,>10000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 108
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Transporter,Rattus norvegicus (rat),Ki, 59
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Cytochrome P450 2D6 (2D6),Homo sapiens (Human),IC50, 960
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,HTR2C,PORCINE,Ki, 9034
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,SLC6A4,MOUSE,Ki, 4.7
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Serotonin (5-HT) receptor,RAT,Ki, 2630.26
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,adrenergic Alpha2,RAT,Ki, 8900
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Cytochrome P450 2C8,Homo sapiens (Human),IC50,>30000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki,>10000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki,>10000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 1000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Cytochrome P450 2D6 (2D6),Homo sapiens (Human),Ki, 4850
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 995
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,P2X purinoceptor 4,RAT,IC50, 2450
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,G protein-coupled receptor kinase 5,Homo sapiens,IC50,>100000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,HTR2C,Beef,Ki,>10000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 80
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Quinolone resistance protein norA,Staphylococcus aureus,IC50, 7000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Muscarinic receptor M2 and M3,RAT,Ki, 42
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,P2X purinoceptor 4,HUMAN,IC50, 1870
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Cytochrome P450 2C9,Homo sapiens (human),IC50,>30000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 72
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Norepinephrine transporter,RAT,Ki, 11.8
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 98
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Cytochrome P450 1A,Homo sapiens (human),IC50, 5330
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,DOPAMINE,RAT,Ki,>10000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Norepinephrine transporter,MOUSE,Ki, 20
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Histamine H1 receptor,RAT,Ki,>10000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki,>10000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Cytochrome P450 3A,Homo sapiens (human),IC50, 24100
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 320
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 5495.4
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Histamine H1 receptor,Homo sapiens (human),Ki,>10000
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 3915
Paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Serotonin 1B/1D receptor,Rattus norvegicus (Rat),Ki,>10000
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,Bile salt export pump (BSEP),Homo sapiens (Human),IC50,>1000000
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,HTR3A,Mus musculus (house mouse),Ki,>10000
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki,>10000
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,Serum albumin,Rattus norvegicus,Kd, 1.0
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki,>10000
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki,>10000
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,Histamine H1 receptor,Homo sapiens (human),Ki,>10000
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,P2X purinoceptor 4,HUMAN,IC50,>100000
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki,>10000
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,Sodium channel alpha subunit,Homo sapiens (Human),Ki, 32700
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,Cytochrome P450 2J2,Homo sapiens (Human),IC50,>50000
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,Glutamate-NMDA,RAT,Ki,>10000
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki,>10000
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,Voltage-gated sodium channel subunit alpha Nav1.4 (Nav1.4),Homo sapiens (Human),Ki, 52000
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,Cytochrome P450 3A,Homo sapiens (human),IC50,>10000
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,P2X purinoceptor 4,HUMAN,IC50,>100000
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,P2X purinoceptor 4,HUMAN,IC50, 15300
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,Voltage-gated potassium channel,Homo sapiens (human),IC50, 104712.85
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,Bile salt export pump,Rattus norvegicus,IC50,>1000000
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,Prion protein,Homo sapiens,EC50,>10000
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,P2X purinoceptor 4,HUMAN,IC50, 100000
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=CC=CC=C12,Bfl-1,Mus musculus (Mouse),IC50,>100000
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=CC=CC=C12,P2X purinoceptor 4,HUMAN,IC50,>10000
Lamotrigine,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,OPIATE Sigma,RAT,IC50,>10000
Lamotrigine,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,Voltage-gated sodium channel subunit alpha Nav1.4 (Nav1.4),Homo sapiens (Human),Ki, 17000
Lamotrigine,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,Sodium channel protein type II alpha subunit,Rattus norvegicus,IC50, 35000
Lamotrigine,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,Voltage-gated sodium channel subunit alpha Nav1.2 (Nav1.2),Homo sapiens (Human),IC50, 10000
Lamotrigine,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,Voltage-gated sodium channel subunit Nav1.5,Homo sapiens (Human),IC50, 39811
Lamotrigine,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,Voltage-gated potassium channel,Homo sapiens (human),IC50, 229086.77
Lamotrigine,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,Voltage-gated potassium channel beta subunit Mink/subunit Kv7.1,Homo sapiens,IC50, 158489
Lamotrigine,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,Voltage-gated sodium channel subunit alpha Nav1.3 (Nav1.3),Homo sapiens (Human),IC50, 17000
Lamotrigine,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,Voltage-gated sodium channel subunit alpha Nav1.8,Rattus norvegicus (Rat),IC50, 25000
Lamotrigine,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,Calcium channel (Type L),HUMAN,IC50, 1258925
Lamotrigine,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,Voltage-gated sodium channel subunit alpha Nav1.8,Homo sapiens (Human),IC50, 96000
Lamotrigine,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,Sodium channel alpha subunit,Homo sapiens (Human),IC50, 17000
Gabapentin,NCC1(CC(O)=O)CCCCC1,Voltage-dependent calcium channel alpha2delta subunit,Sus scrofa,IC50,>10000
Gabapentin,NCC1(CC(O)=O)CCCCC1,Voltage-dependent calcium channel alpha2delta subunit,Sus scrofa,IC50, 420
Gabapentin,NCC1(CC(O)=O)CCCCC1,Voltage-gated calcium channel subunit alpha-2/delta,Homo sapiens (Human),IC50, 27
Gabapentin,NCC1(CC(O)=O)CCCCC1,Voltage-dependent calcium channel alpha2delta subunit,Sus scrofa,IC50,>10000
Gabapentin,NCC1(CC(O)=O)CCCCC1,Voltage-gated calcium channel alpha2/delta subunit 1,Mus musculus,Ki, 120
Gabapentin,NCC1(CC(O)=O)CCCCC1,Voltage-dependent calcium channel alpha2delta subunit,Sus scrofa,IC50, 70
Gabapentin,NCC1(CC(O)=O)CCCCC1,Voltage-dependent calcium channel alpha2delta subunit,Sus scrofa,IC50, 720
Gabapentin,NCC1(CC(O)=O)CCCCC1,Voltage-gated calcium channel alpha2/delta subunit 1,Rattus norvegicus,IC50, 8900
Phenelzine,NNCCC1=CC=CC=C1,Monoamine Oxidase Type B (MAO-B),Rattus norvegicus (rat),IC50, 76.3
Phenelzine,NNCCC1=CC=CC=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki,>10000
Phenelzine,NNCCC1=CC=CC=C1,Lysine-specific histone demethylase 1A,Homo sapiens (Human),IC50, 8.500e+4
Phenelzine,NNCCC1=CC=CC=C1,"Indoleamine 2,3-dioxygenase",Homo sapiens (human),IC50, 14000
Phenelzine,NNCCC1=CC=CC=C1,Monoamine oxidase type B (MAO-B),Homo sapiens (Human),Ki, 94
Phenelzine,NNCCC1=CC=CC=C1,Lysine-specific histone demethylase 1A,Homo sapiens (Human),Ki, 5.6e+3
Phenelzine,NNCCC1=CC=CC=C1,Cytochrome P450 2C8,Homo sapiens (Human),Ki, 1200
Phenelzine,NNCCC1=CC=CC=C1,Vascular adhesion protein 1 (VAP-1),Homo sapiens (Human),IC50, 19.95
Phenelzine,NNCCC1=CC=CC=C1,Sodium-dependent dopamine transporter,Homo sapiens (human),Ki, 8400
Phenelzine,NNCCC1=CC=CC=C1,Monoamine oxidase,Rattus norvegicus (rat),IC50, 30
Phenelzine,NNCCC1=CC=CC=C1,Monoamine oxidase type A (MAO-A),Homo sapiens (Human),Ki, 8.2e+2
Phenelzine,NNCCC1=CC=CC=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki,>10000
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Multidrug and toxin extrusion protein 2,Homo sapiens,IC50, 46000
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Voltage-gated potassium channel,Homo sapiens (human),IC50, 3981.07
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 489.77
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,HTR6,MOUSE,Ki, 398.1
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Serotonin (5-HT) receptor,RAT,Ki,>10000
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Alpha-1 Adrenergic Receptor/ adrenergic receptor/ adrenergic receptor,Rattus norvegicus (Rat),Ki, 367
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Bile salt export pump,Rattus norvegicus,IC50, 369800
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 138.03
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,OPIATE Sigma,RAT,Ki, 48
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,HTR4,RAT,Ki,>10000
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 119
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),IC50, 4
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Bile salt export pump (BSEP),Homo sapiens (Human),IC50, 104500
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Solute carrier family 22 member 2,Homo sapiens,IC50, 12000
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 2089.30
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 13
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),IC50,>1000
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Alpha-1 Adrenergic Receptor/ adrenergic receptor/ adrenergic receptor,Rattus norvegicus (Rat),Ki, 2400
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Sigma,HUMAN,Ki,>2427
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,adrenergic Alpha2,BOVINE,IC50, 10000
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Serotonin 3 (5-HT3) receptor,Homo sapiens (Human),Ki,>10000
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 3.1
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),IC50,>1000
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Multidrug and toxin extrusion protein 1,Homo sapiens,IC50, 1700
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),IC50, 710
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Cerebral cortex alpha adrenergic receptor,CALF,IC50, 16000
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 213.79
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 78
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki,>10000
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 660
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Serotonin 1B/1D receptor,Rattus norvegicus (Rat),Ki, 17
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 3.8
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,HTR1D,RAT,Ki,>10000
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 58
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,DRD1,BOVINE,Ki, 6100
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 13
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Serotonin 2a (5-HT2a) receptor,BOVINE,Ki, 178
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Dopamine D1 receptor,Mus musculus (Mouse),Ki,>1000
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 31.8
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),IC50, 63
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,DRD2,BOVINE,Ki, 44
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Norepinephrine transporter,RAT,Ki, 1000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 0.910000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Substance P,HUMAN,Ki, 1000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Histamine H1 receptor,Homo sapiens (human),Ki, 0.16
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Serotonin 1B/1D receptor,Rattus norvegicus (Rat),Ki, 55
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 6.5
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki, 5000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,DOPAMINE,RAT,Ki, 5
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Histamine H1 receptor,RAT,Ki, 2
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 1.87
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,HTR3A,Mus musculus (house mouse),Ki, 800
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 1000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 0.26
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 1
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 10
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Cysteinyl leukotriene receptor 1,GUINEA PIG,Ki, 1000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki, 1000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Delta-type opioid receptor,MOUSE,Ki, 1000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 0.49
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 0.9
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,"Cholinergic, muscarinic",RABBIT,Ki, 1000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,5-hydroxytryptamine receptor 7 (5HT7),Mus musculus (Mouse),Ki, 0.72
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki, 3.9
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Calcium channel,RAT,Ki, 5000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 1970
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 0.250000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki, 7.3
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Beta-1 adrenergic receptor,Homo sapiens (human),Ki, 5000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 1
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Prostanoid TP receptor,Homo sapiens (Human),Ki, 1000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Serotonin (5-HT) receptor,Homo sapiens,Ki, 11
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 7000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 1.8
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Voltage-gated sodium channel subunit alpha Nav1.8,Rattus norvegicus (Rat),Ki, 630
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 1.1
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,HTR2C,PIG,Ki, 0.17
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Cholecystokinin B,GUINEA PIG,Ki, 1000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 13
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 0.2
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Histamine H2 Receptor,Homo sapiens (human),Ki, 5.7
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 1000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,adrenergic Alpha2,RAT,Ki, 3.7
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 2.5
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 3.8
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 0.13
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,CCKBR,RAT,Ki, 1000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,HTR1D,Bos taurus (Bovine),Ki, 18
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Serotonin (5-HT) receptor,RAT,Ki, 3000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,NT,GUINEA PIG,Ki, 1000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Dopamine receptor,Rattus norvegicus (Rat),Ki, 4.2
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1000
Asenapine,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1,Muscarinic receptor M2 and M3,RAT,Ki, 5000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,D(3) dopamine receptor,Chlorocebus aethiops,Ki, 3
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Human rhinovirus A protease,Human rhinovirus B,Ki, 100
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Voltage-gated sodium channel subunit alpha Nav1.8,Rattus norvegicus (Rat),Ki, 200
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,P-glycoprotein 1,Homo sapiens (Human),Ki, 200
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,CHRM5,Homo sapiens,Ki,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 0.35
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,5-HT2,PIG,Ki, 30
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Dopamine D1 receptor,Sus scrofa,Ki, 9.5
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Angiotensin II type 1a (AT-1a) receptor,RABBIT,Ki,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,HTR4,GUINEA PIG,Ki,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,DRD1,BOVINE,Ki, 315
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Dopamine D1B,RAT,Ki, 35
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,"Cholinergic, muscarinic",RABBIT,Ki, 1000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,OPIATE Sigma,RAT,Ki, 0.9
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Human immunodeficiency virus type 1 protease,Human immunodeficiency virus type 1,Ki, 100
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Adenosine Receptors A2a (A2a),Rattus norvegicus (rat),Ki,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki,>1000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,DRD2,GUINEA PIG,Ki, 1.1
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Glutamate kainate,RAT,Ki,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Adrenergic receptor alpha-2,Homo sapiens (Human),Ki,>5000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Calcium channel,RAT,Ki, 1180
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 150
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Cytochrome P450 2J2,Homo sapiens (Human),IC50, 4690
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Histamine H1 receptor,Homo sapiens (human),Ki, 260
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Voltage-gated L-type calcium channel,Homo sapiens,IC50, 1700
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 1500
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Adrenergic Alpha,HUMAN,IC50, 141900
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,GABA,na,Ki,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Substance P,HUMAN,Ki, 1000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 15.84
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 600
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki, 5000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Cerebral cortex alpha adrenergic receptor,CALF,IC50, 20
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Cytochrome P450 2C9,Homo sapiens (human),IC50,>30000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Dopamine receptor,Rattus norvegicus (Rat),Ki, 2.7
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,5-HT3A Serotonin Receptor,Mus musculus (house mouse),Ki,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 6.17
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Serotonin 1B/1D receptor,Rattus norvegicus (Rat),Ki, 5000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 377.2
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 0.12
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,HTR2C,PIG,Ki, 5000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Voltage-gated potassium channel,Homo sapiens (human),Ki, 120
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,5-HT1,Homo sapiens (human),Ki, 2777.77
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 190
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Glutamate-NMDA,RAT,Ki, 2
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Adrenergic receptor beta,Rattus norvegicus,IC50,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,HTR6,MOUSE,Ki, 501.18
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Sigma,na,Ki, 24
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Cholecystokinin B,GUINEA PIG,Ki, 1000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,HTR3A,GUINEA PIG,Ki, 0.56
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,HTR6,RAT,Ki, 3683
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 25
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,C-8 sterol isomerase,Saccharomyces cerevisiae,Ki, 0.50
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 1202
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Histone H1,Homo sapiens (Human),Ki, 780
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Imidazoline I1,RAT,Ki, 500
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 1000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Serum albumin,Rattus norvegicus,Kd, 9.7
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki,>1000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,"Glycine, non-strychnine",RAT,Ki,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,n-AChR,RAT,Ki,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Kd, 17.38
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 480
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Muscarinic acetylcholine receptor M4,RAT,Ki, 1500
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Angiotensin II AT2,RAT,Ki,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,ADRB2,Rattus norvegicus,Ki,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Sigma-2,RAT,Ki, 24.2
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,HTR1D,Bos taurus (Bovine),Ki, 6950
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Serotonin (5-HT) receptor,RAT,Ki, 1000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,GPR24,RAT,Ki, 350
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Dopamine D2 receptor,Cercopithecus aethiops,Ki, 4.8
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,adrenergic Alpha2,RAT,Ki, 2
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Human herpesvirus 5 chemokine receptor,Human cytomegalovirus (strain AD169) (HHV-5) (Human herpesvirus 5),IC50,>100000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Twik-RElated Potassium (K+) channel 1 (TREK1),Homo sapiens (Human),IC50, 5500
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Delta-type opioid receptor,MOUSE,Ki, 1000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Anti-estrogen binding site (AEBS),Homo sapiens,Ki, 190
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Transporter,Rattus norvegicus (rat),Ki, 5500
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,CCKBR,RAT,Ki, 1000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Serotonin 2a (5-HT2a) receptor,BOVINE,IC50, 30
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,GRIA3,RAT,Ki,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Uridine-5&#39;-diphosphoglucuronosyltransferase 2B7,Homo sapiens (Human),Ki, 590000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Calcium channel,RAT,IC50, 170
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>1000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Adrenergic receptor alpha-1,Homo sapiens (Human),Ki, 19
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Muscarinic receptor M2 and M3,RAT,Ki, 238
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Sodium channel protein type 7 subunit alpha,Homo sapiens,IC50, 7000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki, 270
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,5-hydroxytryptamine receptor 7 (5HT7),Mus musculus (Mouse),Ki, 380
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,NT,GUINEA PIG,Ki, 1000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Sigma,HUMAN,Ki, 0.20
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Serotonin (5-HT) receptor,HUMAN,Ki, 5000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Norepinephrine transporter,RAT,Ki, 1000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Dopamine D1 receptor,Mus musculus (Mouse),Ki, 76
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Cytochrome P450 2C19,Homo sapiens (human),IC50, 2870
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Dopamine receptor,RAT,Ki, 2.3
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki, 40
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Glycine,RAT,Ki,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,DOPAMINE,RAT,Ki, 8.6
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Prostanoid TP receptor,Homo sapiens (Human),Ki, 1000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,HTR7,GUINEA PIG,Ki, 3311.31
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Serotonin (5-HT) receptor,Homo sapiens,Ki, 5000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Sodium-dependent noradrenaline transporter,Homo sapiens (human),Ki, 5500
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Histamine H1 receptor,RAT,Ki, 384
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Dopamine D5 receptor,Homo sapiens (Human),Ki, 38
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Serotonin receptor (2b and 2c),Homo sapiens (human),Ki, 372
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 730
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 0.2
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 3666
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Cytochrome P450 2C8,Homo sapiens (Human),IC50,>30000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Prion protein,Homo sapiens,EC50,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 550
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 35.71
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 0.83
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Cytochrome P450 2D6 (2D6),Homo sapiens (Human),IC50, 3640
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 6.1
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,DRD3,BOVINE,Ki, 6.5
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Adrenergic receptor beta,Rattus norvegicus (Rat),IC50,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Muscarinic receptor M1 and M2,RAT,Ki, 1475
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Alpha adrenergic receptor 1A and 1B,Rattus norvegicus (rat),Ki, 7.2
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Cytochrome P450 1A,Homo sapiens (human),IC50,>30000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Cytochrome P450 3A,Homo sapiens (human),IC50, 8200
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 4670
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,DRD2,BOVINE,Ki, 0.3
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Dopamine D2 receptor,Mus musculus (Mouse),Ki, 2.6
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 0.20
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,UDP-glucuronosyltransferase 1-9,Homo sapiens,Ki, 344000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 1600
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Adenosine receptor A1,Rattus norvegicus (rat),Ki,>10000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,HTR3A,Mus musculus (house mouse),Ki, 5000
Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Cysteinyl leukotriene receptor 1,GUINEA PIG,Ki, 1000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki,>10000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,Ki, 2.8
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.290000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.120000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 24800
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 13.98
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptor,Rattus norvegicus (rat),Ki, 55
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,Kd, 50
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,Ki, 24.7
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,MOUSE,Ki, 0.72
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 4.8
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 4500
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 13.3
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 4500
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 80.5
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.54
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,Ki, 10.6
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 38
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 4.8
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.310000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,Ki, 5.57
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>10000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.120000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,Ki, 24
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu opioid receptor,CALF,Ki, 3.3
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 880
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 3388
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1400
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptor,Rattus norvegicus (rat),Kd, 1
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,MOUSE,Ki, 14
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.0825
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1995
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki,>7000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,Ki, 2.8
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 281
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 3.73
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,IC50, 9.70
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki,>6000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Norepinephrine transporter,RAT,Ki,>10000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 13.3
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.26
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.410000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,Ki, 4.6
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,MOUSE,Ki, 0.31
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 2.5
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1200
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,Ki, 9.3
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 5.4
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.15
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.86
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Norepinephrine transporter,RAT,Ki,>10000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.3
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 36
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 304
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.09
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 3.67
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,Ki, 32
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),IC50, 21
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 901
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 35
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 1087
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,MOUSE,Ki, 14
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin receptor,Homo sapiens (human),Ki,>10000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,neuropeptides B/W receptor 1,Homo sapiens,Ki, 3000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,IC50, 17.6
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1700
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.4
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki,>6000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,MOUSE,Ki, 18
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,Ki, 144
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Adenosine receptors; A1 & A2a,Homo sapiens (human),Ki,>50000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki,>7000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.300000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,OPRD1,GUINEA PIG,Ki, 13.5
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.7
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.810000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mas-related G protein-coupled receptor X2 (MRGPRX2),Homo sapiens (Human),EC50, 1.1e+4
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.047000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,Ki, 26.3
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,MOUSE,Ki, 28
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,IC50, 2
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,Ki, 294
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.010000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50, 19
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Acetylcholinesterase,Electrophorus electricus (Electric eel),IC50, 65300
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 25
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,IC50, 2.4
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,"Nociceptin/Orphanin FQ, NOP receptor",MOUSE,Ki, 1000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.430000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 272
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,MOUSE,Ki, 0.330000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.130000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,MOUSE,Ki, 125
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1700
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,"Nociceptin/Orphanin FQ, NOP receptor",MOUSE,Ki, 1000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 2.46
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.97
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 209
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 25.2
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.6
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 147
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,Ki, 26.4
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Kd, 18
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.1
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,IC50, 63
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>3000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,IC50, 0.5
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 41
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki,>10000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 3000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,Ki, 86
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 3.2
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.540000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,IC50, 30.5
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 57.6
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 8.76
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,Ki, 8.3
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,Ki, 5.5
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 7.4
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 5.02
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.46
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.230000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Acetylcholinesterase,Electrophorus electricus (Electric eel),IC50, 140100
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.2
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.34
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki,>3000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 6700
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,Ki, 0.028000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.15
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.250000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 4.8
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.5
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.480000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.023
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,n-AChR,RAT,Ki,>10000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.2
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.190000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,OPIATE Sigma,RAT,Ki, 3500
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,IC50, 24.4
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Vesicular acetylcholine transporter,Homo sapiens,IC50,>100000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.1
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptor,Rattus norvegicus (rat),Ki, 25.2
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 133.48
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.61
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.18
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 8.69
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,IC50, 6.1
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 7500
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,MOUSE,Ki, 2.8
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,MOUSE,Ki, 9.2
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 1.4
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.280000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,Ki, 118
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1.9
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Adenosine receptor A3,Homo sapiens (human),IC50, 1.6
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 6.5
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Acetylcholinesterase,Electrophorus electricus (Electric eel),IC50, 76200
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 43.60
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 9.2
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,MOUSE,Ki, 20.3
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 900
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 6.12
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 260
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 9.5
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,OPRD1,GUINEA PIG,Ki, 6.5
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 1.4
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,IC50, 840
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,MOUSE,Ki, 0.44
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 2.8
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,Kd, 1.86
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,IC50, 0.8
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 1029
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>1000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.08
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,C-C chemokine receptor type 5,Mus musculus,Kd, 11
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,DRD1,BOVINE,Ki,>10000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>10000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 210
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,Ki, 31
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,OPRK1,Frog,Ki, 0.9
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 5.18
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,Ki, 182
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 33
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 3.9
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,Ki, 0.0019
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 14.38
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 4.8
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 39
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 83.2
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),IC50, 17
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptor,Rattus norvegicus (rat),Ki, 0.509
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 15
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,Ki, 8.95
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 105500
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Neuronal acetylcholine receptor protein alpha-7 subunit,Homo sapiens (human),IC50, 25000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 4.05
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 1.4
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.25
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.200000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.820000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu/kappa/delta,Homo sapiens (human),Ki, 13
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 102
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 2.14
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Cytochrome P450 2J2,Homo sapiens (Human),IC50,>50000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 1.25
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,MOUSE,Ki, 119
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.37
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 0.930
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 4467
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 5.1
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 33.8
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Kd, 0.400000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Neuronal acetylcholine receptor,Rattus norvegicus (Rat),IC50, 31000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.280000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptor,Rattus norvegicus (rat),Ki, 26.9
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,MOUSE,Ki, 0.38
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 0.920
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 3.14
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 5700
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 86
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 128
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,IC50, 1.9
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 2.46
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 6.2
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 4467
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 2.92
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 3400
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 33
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Norepinephrine transporter,RAT,Ki,>10000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,Ki, 1.17
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 72.6
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki, 88
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,IC50, 2.3
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Kd, 20
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 25
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,Ki, 0.170000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1.18
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 275
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 61.4
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),IC50,>1000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,"Cholinergic, muscarinic",RABBIT,Ki, 67.4
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,IC50, 0.9
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 16
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki,>7200
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.560000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 16.31
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,MOUSE,Ki, 7.8
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),EC50,>92384
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu/kappa/delta,Homo sapiens (human),Ki, 208
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,IC50,>1000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 2000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 200
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptor,Rattus norvegicus (rat),Ki, 95
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.81
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Sigma,HUMAN,Ki,>100000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 588
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.11
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opiate non-selective,GUINEA PIG,Ki, 1.4
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,Ki, 610
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 8.02
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.1
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 13
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 41
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,IC50,>1000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 20.14
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.490
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.340000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 7.38
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 5.36
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 40
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 8.81
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.410000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.070000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),IC50, 182
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,OPRD1,Bos taurus,Ki, 18.5
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,IC50, 0.9
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 39
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 3.7
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 14
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 50
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki,>3000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 1.4
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 19.92
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>3000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>1000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 10.2
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,IC50, 1.5
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.09
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 13.3
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Sodium-dependent serotonin transporter,Rattus norvegicus (rat),Ki,>10000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1.63
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Dopamine receptor,Rattus norvegicus (Rat),Ki,>20000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,MOUSE,Ki, 5.01
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 10.2
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.16
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptor,Rattus norvegicus (rat),Ki, 677
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,Ki, 3.36
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1,Homo sapiens,IC50, 9735
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 68.4
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptors; mu & delta,Rattus norvegicus (rat),Ki, 5.34
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1400
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,MOUSE,Ki, 0.646
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,GUINEA PIG,IC50, 1.5
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 3.8
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Opioid receptor,Rattus norvegicus (rat),Ki, 2658
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),IC50,>1000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 17
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 2
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,MOUSE,Ki, 0.0041
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1.1
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 6.3
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.18
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor,Homo sapiens (human),Ki, 0.140000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Toll-like receptor 4/MD-2/CD14,Mus musculus,IC50, 1800
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki,>10000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 7.1
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Delta-type opioid receptor,Homo sapiens (human),Ki, 0.250000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Mu-type opioid receptor,Homo sapiens (human),Ki, 0.550000
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 0.12
Naloxone,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,Kappa-type opioid receptor (KOR),Mus musculus (Mouse),Ki,>1000
Oxazepam,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,Translocator protein,Homo sapiens (Human),IC50, 3499451670.28
Oxazepam,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,Liver fatty acid binding protein (rat L-FABP),Rattus norvegicus (Rat),Ki, 12900
Oxazepam,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,Translocator protein,Homo sapiens (Human),IC50, 15995580286.15
Oxazepam,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,Serum albumin,Homo sapiens,Kd, 69183
Oxazepam,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,Translocator protein,Homo sapiens (Human),IC50, 17988709151.29
Oxazepam,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 350
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,Translocator protein,Homo sapiens (Human),IC50, 3499451670.28
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,Liver fatty acid binding protein (rat L-FABP),Rattus norvegicus (Rat),Ki, 12900
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,Translocator protein,Homo sapiens (Human),IC50, 1798870915.13
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,Serum albumin,Homo sapiens,Kd, 69183
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,Translocator protein,Homo sapiens (Human),IC50, 17988709151.29
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 350
Zuclopenthixol,OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,ubiquitin-conjugating enzyme E2 N,Homo sapiens,IC50,>20000
Zuclopenthixol,OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 169
Zuclopenthixol,OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,DRD2,BOVINE,Ki, 88
Zuclopenthixol,OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,DRD1,BOVINE,Ki,>10000
Zuclopenthixol,OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,DRD2,BOVINE,Ki, 3.1
Zuclopenthixol,OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,DRD1,BOVINE,Ki, 480
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 24
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,DRD2,BOVINE,Ki, 0.3
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 14.08
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 1001
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Dopamine D1 receptor,Mus musculus (Mouse),Ki, 4.5
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,DRD1,BOVINE,Ki, 18
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,OPIATE Sigma,RAT,Ki, 62
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Histamine receptor (H3),Homo sapiens (human),Ki,>1000
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Sigma,HUMAN,Ki, 15
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Dopamine D5 receptor,Homo sapiens (Human),Ki, 14
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 1886.79
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 38
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 0.11
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,P-glycoprotein 1,Homo sapiens (Human),Ki, 6500
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Trypanothione reductase,Trypanosoma cruzi,Ki, 21200
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 32.2
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,HTR3A,Mus musculus (house mouse),Ki,>10000
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,HTR6,RAT,Ki, 66
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 188.67
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Calmodulin,Homo sapiens,Kd, 1000
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 28.8
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,C-8 sterol isomerase,Saccharomyces cerevisiae,Ki, 500
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 6.5
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Kd, 0.532000
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 1441
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,DRD2,CANINE,Ki, 1.2
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Histamine H1 receptor,Homo sapiens (human),Ki, 62
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Dopamine D2 receptor,Mus musculus (Mouse),Ki, 0.84
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 653.7
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Anti-estrogen binding site (AEBS),Homo sapiens,Ki, 8
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 0.96
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Beta-glucuronidase,Rattus norvegicus,IC50, 7800
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Adrenergic receptor alpha-2,NEONATAL RAT,Ki, 320
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,DRD2,CANINE,Ki, 0.5
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 290.8
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 0.25
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,5-HT1,Homo sapiens (human),Ki,>10000
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,HTR6,RAT,Ki, 15.85
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Pleiotropic ABC efflux transporter of multiple drugs,Saccharomyces cerevisiae S288c,IC50, 1700
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 7.1
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,P-glycoprotein 1,Homo sapiens (Human),IC50, 5700
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 100
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 4
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 13
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 304
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Histamine H1 receptor,Homo sapiens (human),Ki, 21
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,DNA-dependent protein kinase,Homo sapiens (Human),IC50, 100000
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 950
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,HTR7,GUINEA PIG,Ki, 1445.43
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,NADPH oxidase 1,Homo sapiens,IC50,>17000
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Dopamine receptor,RAT,Ki, 19
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Calmodulin,Bos taurus,Kd, 3400
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 7
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,NADPH oxidase 1,Homo sapiens,IC50,>17000
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,5-HT1,Homo sapiens (human),Ki,>10000
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Histamine H1 receptor,RAT,Ki, 182
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 630.95
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 163.6
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 0.2
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 8
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,"Hepatitis C virus serine protease, NS3/NS4A",Hepatitis C virus,IC50, 700
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Trypanothione reductase,Trypanosoma cruzi,Ki, 23000
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 1.99
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Emopamil-binding protein-like,Homo sapiens,Ki, 3.9
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Serum albumin,Rattus norvegicus,Kd, 1.4
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 345
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Dopamine receptor,Rattus norvegicus (Rat),Ki, 0.71
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Lysozyme C,Rattus norvegicus,IC50, 9000
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 145.7
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,DOPAMINE,RAT,Ki, 4.5
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Dopamine receptor,RAT,Ki, 9.3
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 3.2
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Histamine H1 receptor,RAT,Ki, 67
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 44
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Pleiotropic ABC efflux transporter of multiple drugs,Saccharomyces cerevisiae S288c,IC50, 1400
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 81.6
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Bfl-1,Mus musculus (Mouse),IC50,>20000
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Kinesin-like protein 1,Homo sapiens,IC50, 6600
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,ADRA2C,OK,Ki, 122
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 660
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 0.45
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,DRD2,BOVINE,Ki, 2.1
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,ubiquitin-conjugating enzyme E2 N,Homo sapiens,IC50, 17334
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 118
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Adrenergic Alpha,HUMAN,IC50, 110000
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Twik-RElated Potassium (K+) channel 1 (TREK1),Homo sapiens (Human),IC50, 4700
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Androgen receptor,Rattus norvegicus (Rat),Ki, 800
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,DRD1,BOVINE,Ki, 740
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,ubiquitin-conjugating enzyme E2 N,Homo sapiens,IC50,>20000
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,TPA: Essential protein of the mitochondrial intermembrane space,Saccharomyces cerevisiae S288c,IC50, 31300
Fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 391.5
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine receptor,RAT,Ki, 1164
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Alpha-2B adrenergic receptor,Homo sapiens (Human),Ki, 90
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),IC50, 417
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Nociceptin/mu opioid receptor,Rattus norvegicus (rat),Ki, 1000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,NT,GUINEA PIG,Ki, 1000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),IC50, 560
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,5-hydroxytryptamine receptor 1D,Homo sapiens (human),Ki, 560
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Muscarinic receptor M2 and M3,RAT,Ki, 56
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 16
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Cholecystokinin B,GUINEA PIG,Ki, 1000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Muscarinic acetylcholine receptor M2 and M4,HUMAN M3,Ki, 225
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,HTR6,RAT,Ki, 1297
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Alpha-1A adrenergic receptor,Rattus norvegicus (Rat),Ki, 4.5
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Serotonin (5-HT) receptor,RAT,Ki, 170
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,5-Hydroxytryptamine receptor 1A (5-HT1A),Homo sapiens (human),Ki, 125
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Histamine H1 receptor,Homo sapiens (human),Ki, 2.2
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Substance P,HUMAN,Ki, 1000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Prostanoid TP receptor,Homo sapiens (Human),Ki, 1000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Serotonin (5-HT) receptor,HUMAN,Ki, 2240
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Adrenergic receptor alpha-2,Homo sapiens (Human),Ki, 87
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) alpha-1),Rattus norvegicus (Rat),Ki, 1000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),IC50, 1330
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),IC50, 1640
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine receptors; D3 & D4,Homo sapiens (Human),Ki, 9.2
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,CCKBR,RAT,Ki, 1000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dihydrofolate Reductase (DHFR),Bacillus anthracis,IC50, 102000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine receptors; D2 & D4,Homo sapiens (Human),Ki, 500
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Muscarinic receptor M1 and M2,RAT,Ki, 120
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine receptor,Rattus norvegicus (Rat),Ki, 180
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,adrenergic Alpha2,RAT,Ki, 87
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,HTR3A,Mus musculus (house mouse),Ki, 4060
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Histamine H1 receptor,RAT,Ki, 11
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),Ki, 69
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Alpha-2C adrenergic receptor,Homo sapiens (Human),Ki, 28.7
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Voltage-gated sodium channel subunit alpha Nav1.8,Rattus norvegicus (Rat),Ki, 5000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine D5 receptor,Homo sapiens (Human),Ki, 1513
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,5-Hydroxytryptamine receptor 6 (5-HT6),Homo sapiens (human),Ki, 33
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Delta-type opioid receptor,MOUSE,Ki, 1000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine D1 and D2 receptor,Homo sapiens (Human),Ki, 390
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Serotonin receptor 2a and 2c (5HT2A and 5HT2C),Rattus norvegicus (Rat),Ki, 1500
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),IC50, 166
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,5-hydroxytryptamine receptor 1B,Homo sapiens (human),Ki, 2050
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),IC50, 795
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Sigma-1 receptor,Cavia porcellus (Guinea pig),Ki, 220
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine receptor D2L/neurotensin receptor NTS1,Homo sapiens (Human),Ki, 37
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,mu/kappa opioid receptor,Cavia porcellus (domestic guinea pig),Ki, 1000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Serotonin (5-HT) receptor,Homo sapiens,Ki, 1250
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Muscarinic acetylcholine receptor M2,Homo sapiens (Human),Ki, 630
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Voltage-dependent L-type calcium channel subunit alpha-1C,Cavia porcellus,IC50, 10400
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,CHRM5,Homo sapiens,Ki, 2990
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Beta-1 adrenergic receptor,Homo sapiens (human),Ki, 5000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine Transporter (DAT),Rattus norvegicus (rat),Ki, 1000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,HTR2C,PIG,Ki, 3820
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Histamine H1 receptor,Cavia porcellus (domestic guinea pig),Ki, 19
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,"Cholinergic, muscarinic",RABBIT,Ki, 1000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Histone H1,Homo sapiens (Human),Ki, 10
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),IC50, 755
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Serotonin (5-HT) receptor,Rattus norvegicus (rat),Ki, 82
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,5-hydroxytryptamine receptor 7 (5HT7),Mus musculus (Mouse),Ki, 290
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Alpha-2A adrenergic receptor,Homo sapiens (Human),Ki, 80
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,HTR1D,Bos taurus (Bovine),Ki, 6220
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Cysteinyl leukotriene receptor 1,GUINEA PIG,Ki, 1000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Voltage-gated sodium channel subunit Nav1.5,Homo sapiens (Human),IC50, 16900
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Calcium channel,RAT,Ki, 5000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Voltage-gated potassium channel,Homo sapiens (human),Ki, 5765
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,5-Hydroxytryptamine receptor 2C (5-HT2C),Homo sapiens (human),Ki, 615
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),IC50, 1394
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Adrenergic beta-2 receptor (beta2),Homo sapiens (Human),Ki, 5000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Serotonin 1B/1D receptor,Rattus norvegicus (Rat),Ki, 5000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor,Rattus norvegicus (rat),IC50, 132
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Serotonin and norepinephrine transporters (SERT/NET),Homo sapiens (human),Ki,>1000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Muscarinic acetylcholine receptor,Homo sapiens (Human),Ki, 705
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Transporter,Rattus norvegicus (rat),Ki, 680
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,DOPAMINE,RAT,Ki, 390
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,5-Hydroxytryptamine receptor 2A (5-HT2A),Homo sapiens (human),Ki, 31
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Alpha-1A adrenergic receptor,Homo sapiens (Human),Ki, 8.1
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Norepinephrine transporter,RAT,Ki, 1000
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Muscarinic acetylcholine receptor M4,RAT,Ki, 660
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Adrenergic receptor alpha-1,Homo sapiens (Human),Ki, 58
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Muscarinic acetylcholine receptor M1 (M1),Homo sapiens (Human),Ki, 56
Quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,5-Hydroxytryptamine receptor 7 (5-HT7),Homo sapiens (human),Ki, 307.2
